The NACE Clinical Highlights Show: Recent Episodes
NACE
Engage with NACE moderators guest hosts, and expert NACE faculty for discussions about current clinical strategies for common and rare health conditions that you can use in clinical practice immediately, and that works for you and your patients.
The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:
1. Step Accumulation Patterns and Risk for Cardiovascular Events and
Mortality Among Suboptimally Active Adults – Annals of Internal Medicine 2025. Discussion by:
Guest:
Kathryn Donnelly, DO
Resident - Family Medicine Residency Program
Jefferson Health - Abington
2. Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Obesity – The New England Journal of Medicine 2025. Discussion by:
Guest:
Ajay Rau, MD
Chief - Section of Endocrinology, Diabetes and Metabolism
Lewis Katz School of Medicine at Temple University
3. Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation. New England Journal Of Medicine 2025. Discussion by:
Guest:
Jasmin Walker, MD
Resident – Family Medicine Residency Program
Jefferson Health – Abington
Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA.
This Podcast Episode does not offer CME/CE Credit.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:
1. Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity – The New England Journal of Medicine 2025. Discussion by:
Guest:
Anupryia Grover-Wenk, DO
Resident - Family Medicine Residency Program
Jefferson Health - Abington
2. Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2
Diabetes. – The New England Journal of Medicine 2025.Discussion by:
Guest:
Samantha Traslaviña, DO
Resident– Family Medicine Residency Program
Jefferson Health – Abington
3. Cycling and education intervention versus usual physiotherapy care for the treatment of hip osteoarthritis in the UK (CLEAT): a pragmatic, randomised, controlled trial. Lancet Rheumatology 2025. Discussion by:
Guest:
Sean Cleary, DO
Resident– Family Medicine Residency Program
Jefferson Health – Abington
Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA.
This Podcast Episode does not offer CME/CE Credit.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:
1. Structured vs Self-Guided Multidomain Lifestyle Interventions for Global Cognitive Function: The US POINTER Randomized Clinical Trial JAMA 2025. Discussion by:
Guest:
Philip Lieberman, MD
Resident- Family Medicine Residency Program
Jefferson Health - Abington
2. Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity — A Phase 2 Trial. New England Journal of Medicine 2025 Discussion by:
Guest:
Donna Ryan, MD
Professor Emerita at Pennington Biomedical
Baton Rouge, LA, USA
3. Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer’s disease: a randomized, controlled clinical trial. Alzheimer’s Research & Therapy. Discussion by:
Guest:
Kathryn Donnelly, DO
Resident– Family Medicine Residency Program
Jefferson Health – Abington
Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA.
This Podcast Episode does not offer CME/CE Credit.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:
https://www.mycme.com/courses/personalizing-care-identifying-the-right-patients-for-new-treatments-10268
SummaryDr. Genevieve Neal-Perry and Dr. Andrea Singer focus on practical strategies in the personalized management of menopausal vasomotor symptoms (VMS). The discussion covers the importance of routine and individualized screening for VMS, with attention to healthcare disparities and the diverse ways menopause is discussed and experienced across populations, before covering patient selection criteria for newer non-hormonal treatments.
This podcast was recorded and is being used with permission of the presenters.
Learning Objectives
- Integrate routine and individualized screening methods to identify patients with menopausal VMS, with attention to healthcare disparities
- Integrate new and emerging agents into the treatment of women with menopausal VMS, based on patient characteristics and preference
This activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0 hours of pharmacology).
For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.
Summary of Individual DisclosuresPlease review faculty and planner disclosures here.
Disclosure of Commercial SupportThis educational activity is supported in part by an educational grant from Bayer HealthCare Pharmaceuticals Inc.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:
https://www.mycme.com/courses/targeting-cause-emerging-therapies-menopausal-vms-10267
SummaryThis enduring podcast activity explores groundbreaking advancements in the treatment of menopausal vasomotor symptoms (VMS), emphasizing non-hormonal therapies. Dr. Andrea Singer and Dr. Genevieve Neal-Perry discuss the underlying biology of menopause, particularly the role of neurokinin (NK) receptors, and introduces the science behind new therapeutic agents, as well as their clinical trial data.
This podcast was recorded and is being used with permission of the presenters.
Learning ObjectiveDiscuss the clinical trial data for new and emerging non-hormonal therapies
This activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0.25 hours of pharmacology).
For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.
Summary of Individual DisclosuresPlease review faculty and planner disclosures here.
Disclosure of Commercial SupportThis educational activity is supported in part by an educational grant from Bayer HealthCare Pharmaceuticals Inc.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:
1. Antihypertensive Medication Timing and Cardiovascular Events and Death The BedMed Randomized Clinical Trial JAMA 2025. Discussion by:
Guest:
Susan Kuchera, MD
Director of the Family Medicine Residency Program
Jefferson Health - Abington
2. Weekly Fixed-Dose Insulin Efsitora in Type 2 Diabetes without Previous Insulin Therapy. 2025. Discussion by:
Guest:
Eden Miller, MD
Diabetes and Obesity Specialist
Bend, Oregon
3. As-Needed Albuterol–Budesonide in Mild Asthma. The New England Journal of Medicine. Discussion by:
Guest:
Dylan Selden, MD
Resident– Family Medicine Residency Program
Jefferson Health – Abington
Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA.
This Podcast Episode does not offer CME/CE Credit.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:
https://www.mycme.com/courses/strategies-and-real-world-impact-of-the-stimulant-crisis-10220
Summary
The stimulant medication shortage has introduced new challenges in managing ADHD, affecting both patients’ access to essential treatments and clinicians’ ability to provide consistent care. In this PsychTalk podcast/webcast episode, Drs. Gregory Mattingly and Roger McIntyre explore the impact of these shortages, particularly on cognitive functioning, treatment continuity, and daily life for individuals with ADHD. Their discussion also examines stimulant misuse and diversion, looking at trends in medication sourcing, formulations most susceptible to abuse, and strategies to reduce the risk of misuse. By the end of the episode, learners will be equipped with timely insights and real-world tools to optimize ADHD management amid evolving supply and safety challenges.
This podcast was recorded and is being used with permission of the presenters.
Learning ObjectivesAt the conclusion of this activity, participants should be better able to:
- Describe the impact of stimulant shortages on individuals with ADHD
- Incorporate best-practice clinical strategies to minimize the risk of stimulant misuse in the treatment of ADHD
This activity is accredited for CME/CE Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which includes 0.50 hours of pharmacology).
For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.
Summary of Individual DisclosuresPlease review faculty and planner disclosures here.
Disclosure of Commercial Support
This activity is not supported by an educational grant.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:
http://mycme.com/courses/the-cognitive-side-of-major-depressive-disorder-10221
Summary
Despite significant improvements in mood symptoms, many patients with MDD continue to experience persistent residual symptoms—particularly cognitive impairments—that hinder full functional recovery. In this PsychTalk podcast/webcast episode, Drs. Gregory Mattingly and Roger McIntyre discuss the often-overlooked role of cognitive dysfunction in MDD recovery, highlighting how these impairments correlate strongly with reduced workplace productivity, social withdrawal, and elevated relapse risk, ultimately impeding long-term outcomes. Their conversation provides listeners with an in-depth understanding of the presentation of cognitive impairment and residual symptoms in MDD, as well as strategies to foster resilience, enhance patient engagement, and promote functional recovery.
This podcast was recorded and is being used with permission of the presenters.
Learning ObjectivesAt the conclusion of this activity, participants should be better able to:
- Recognize the clinical significance of residual symptoms in MDD, with a focus on cognitive impairment, and their impact on patient functioning and treatment outcomes
This activity is accredited for CME/CE Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.75 contact hours (which includes 0.25 hours of pharmacology).
Summary of Individual DisclosuresPlease review faculty and planner disclosures here.
Disclosure of Commercial Support
This educational activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/the-latest-data-in-ckd-progression-10197
SummaryEmerging evidence highlights the potential of GLP-1 receptor agonists (GLP-1 RAs) to slow CKD progression and reduce cardiovascular and kidney-related mortality in patients with type 2 diabetes (T2D) and chronic kidney disease (CKD). Yet, despite updated guidelines, these therapies remain underused. This program will explore the latest clinical data supporting the role of GLP-1 RAs in risk mitigation and provide practical strategies for implementing guideline-based treatment to reduce cardio-renal risk and improve outcomes in patients with T2D and CKD.
This podcast was recorded and is being used with permission of the presenters.
Learning ObjectivesAt the conclusion of this activity, participants should be better able to:
- Discuss emerging data on GLP-1 RA therapy for CKD progression in T2D
- Implement guideline-based care to minimize CV risk and CKD progression
This activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0.25 hours of pharmacology).
For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.
Summary of Individual DisclosuresPlease review faculty and planner disclosures here.
Disclosure of Commercial SupportThis activity is supported by an educational grant from Novo Nordisk.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:
1. Effects of Combining Coronary Calcium Score With Treatment on Plaque
Progression in Familial Coronary Artery Disease A Randomized Clinical Trial JAMA 2025. Discussion by:
Guest:
Michael J. Blaha, MD, MPH
Professor of Cardiology and Epidemiology and presently serves as the
Director of Clinical Research for the Johns Hopkins Ciccarone Center for the
Prevention of Cardiovascular Disease
Director of the Cardiometabolic Clinic
Program Director for the Preventive Cardiology Fellowship.
2. Creatine monohydrate pilot in Alzheimer’s: Feasibility, brain creatine, and cognition. Alzheimer’s Dement. 2025. Discussion by:Guest:Michael Devano, DO
Attending Family Physician
Christiana Care Health System
3. Structured Exercise after Adjuvant Chemotherapy for Colon Cancer. The New England Journal of Medicine. Discussion by:
Guest:
Joseph Gonnella, MD
Resident– Family Medicine
Residency Program, Jefferson Health – Abington
Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA.
This Podcast Episode does not offer CME/CE Credit.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/answers-in-chronic-spontaneous-urticaria-10190
SummaryIn this short CE/CME activity, moderator Dr. Brad Glick works with dermatology expert Dr. Gil Yosipovitch to answer your top questions regarding chronic spontaneous urticaria, as gathered from the 2025 NACE Conversations in Dermatology symposium. Questions cover diagnosis, treatment individualization, and more!
Learning ObjectivesAt the conclusion of this activity, participants should be better able to:
- Assess the disease burden and impact on QoL in patients with CSU
- Evaluate current and emerging therapies for CSU
This activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0.25 hours of pharmacology).
For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.
Summary of Individual DisclosuresPlease review faculty and planner disclosures here.
Disclosure of Commercial SupportThis activity is supported by an independent educational grant from Sanofi and Regeneron Pharmaceuticals.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/copd-inflammation-exacerbations-your-questions-answered-10143
SummaryRejoin the conversation on COPD, inflammation, and new and emerging agents as two of our expert faculty come together to answer your top questions. Questions submitted from the recent Conversations in Primary Care live virtual symposia guide the discussion as we dig a bit deeper on type 2 inflammation, changes in COPD management, and new and emerging agents – including recently approved biologic agents – for COPD.
Learning ObjectivesAt the conclusion of this activity, participants should be better able to:
- Review the relationship between inflammation, exacerbation, and disease progression in COPD, noting different inflammatory endotypes of patients with COPD
- Discuss recent evidence surrounding the use of biologic agents in the management of patients with COPD and type 2 inflammation
- Integrate current guidelines with clinical data on new and emerging agents for the management of COPD, distinguishing patients with and without markers of type 2 inflammation
This activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0.25 hours of pharmacology).
For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.
Summary of Individual DisclosuresPlease review faculty and planner disclosures here.
Disclosure of Commercial SupportThis activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc and Sanofi.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:
1. Lepodisiran — A Long-Duration Small Interfering RNA Targeting Lipoprotein(a) - New England Journal of Medicine 2025. Discussion by:
Guest:
Steven E. Nissen, M.D.,
Chief Academic Officer of the Heart and Vascular Institute at the Cleveland Clinic
Professor of Medicine at the Lerner College of Medicine
2. Genitourinary Syndrome of Menopause: AUA/SUFU/AUGS Guideline (2025).
Discussion by: Discussion by:Guest:Anupriya Grover-Wenk, DO
Faculty– Family Medicine Residency Program
Jefferson Health – Abington
3. Liberal fluid intake versus fluid restriction in chronic heart failure: a randomized clinical trial. Discussion by:
Guest:
Joseph Gonnella, MD
Resident– Family Medicine Residency Program
Jefferson Health – Abington
Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA.
This Podcast Episode does not offer CME/CE Credit.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/psychiatric-therapeutics-in-a-digital-world-10096 SummaryIn this PsychTalk podcast/webcast episode, Drs. Gregory Mattingly and Lisa Harding delve into the digital world and breakdown its effects on mental health—both positive and negative. By the end of the episode, learners will have a better understanding of the relationship between screen time, social media, and attention, including clinical pearls for how to harness prescription technology to enhance patient outcomes in ADHD and depression.
This podcast was recorded and is being used with permission of the presenters.
Learning ObjectivesAt the conclusion of this activity, participants should be better able to:
- Examine the relationship between social media and attention
- Incorporate FDA-authorized digital therapeutics into ADHD and depression management plans based on current clinical evidence
This activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which does not include hours of pharmacology).
For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.
Summary of Individual DisclosuresPlease review faculty and planner disclosures here.
Disclosure of Commercial SupportThis educational activity is not commercially supported.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/clinical-updates-in-schizophrenia-10097 SummaryIn this PsychTalk podcast/webcast episode, Drs. Gregory Mattingly and Lisa Harding go through the evolving landscape of schizophrenia treatments. Listen as they discuss the pros and cons of various second-generation antipsychotics, the science behind muscarinic modulation for psychosis, and recent updates in clozapine prescribing. At the end of the session, the doctors answer several audience questions to enhance your understanding of these developments and how they apply to clinical practice.
This podcast was recorded and is being used with permission of the presenters.
Learning ObjectivesAt the conclusion of this activity, participants should be better able to:
- Integrate recent clinical data on antipsychotic treatments and relapse prevention strategies into management plans for patients with schizophrenia
- Describe the role of muscarinic modulation in psychosis
This activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.75 contact hours (which includes 0.75 hours of pharmacology).
For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.
Summary of Individual DisclosuresPlease review faculty and planner disclosures here.
Disclosure of Commercial SupportThis educational activity is not commercially supported.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:
1. Adverse Outcomes Associated With Inhaled Corticosteroid Use in Individuals With Chronic Obstructive Pulmonary Disease. Annals of Family Medicine 2025. Discussion by:
Guest:
Barbara Yawn, MD, MSc, MPH
Adjunct Professor, Department of Family and Community Health
University of Minnesota
Former Chief Scientific Officer at the COPD Foundation
2. Optimal dietary patterns for healthy aging. Nature Medicine. Discussion by:Guest:Jessica Stieritz, MD
Resident– Family Medicine Residency Program
Jefferson Health – Abington
3. Amount and intensity of daily total physical activity, step count and risk of incident cancer. British Journal of Sports Medicine. Discussion by:
Guest:
William Callahan, D.O.
Associate Director – Family Medicine Residency Program
Jefferson Health – Abington
Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA.
This Podcast Episode does not offer CME/CE Credit.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/practical-management-for-complex-psychiatric-cases-10046 SummaryIn this PsychTalk podcast/webcast episode, Drs. Gregory Mattingly and Lisa Harding teach by case example. Listeners will hear an introduction to a complex patient presentation and then be taken through expert strategies to discern the correct diagnoses. The program will conclude with the same case example to tie together the education and demonstrate these strategies in practice.
This podcast was recorded and is being used with permission of the presenters.
Learning ObjectiveAt the conclusion of this activity, participants should be better able to:
- Apply evidence-based strategies to develop personalized treatment plans when managing patients with comorbid mental health disorders
This activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.75 contact hours (which does not include hours of pharmacology).
For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.
Summary of Individual DisclosuresPlease review faculty and planner disclosures here.
Disclosure of Commercial SupportThis educational activity is not commercially supported.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/characterizing-connected-conditions-in-psychiatry-10045 SummaryIn this PsychTalk podcast/webcast episode, Drs. Gregory Mattingly and Lisa Harding discuss some of the complexities of mental health care: overlapping symptoms and differential diagnoses. Listeners will learn about the connections between certain psychiatric disorders and how symptom combinations may influence treatment and patient outcomes. The program will also review strategies to help with accurate diagnoses in complex patient presentations, teaching listeners how to take a thorough patient history and use that information to guide treatment decisions.
This podcast was recorded and is being used with permission of the presenters.
Learning ObjectivesAt the conclusion of this activity, participants should be better able to:
- Describe the impact of comorbid mental health diagnoses on patient outcomes
- Employ strategies to aid in the differential diagnosis of patients who present with symptoms suggestive of multiple mental health conditions
This activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which does not include hours of pharmacology).
For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.
Summary of Individual DisclosuresPlease review faculty and planner disclosures here.
Disclosure of Commercial SupportThis educational activity is not commercially supported.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:
1. Filling the Evidence Gaps Toward a Coronary Artery Calcium-Guided Primary Prevention Strategy. JAMA Cardiology 2025. Discussion by:
Guest:
Michael J. Blaha, MD, MPH
Professor of Cardiology and Epidemiology and presently serves as the
Director of Clinical Research for the
Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease
2. Male-Partner Treatment to Prevent Recurrence of Bacterial Vaginosis. New England Journal of Medicine. Discussion by:Guest:Amreen Syed, DO
Resident– Family Medicine Residency Program
Jefferson Health – Abington
3. Intranasal Versus Oral Treatments for Allergic Rhinitis: A Systematic Review With Meta-Analysis Journal of Allergy and Clinical Immunology in Practice3. Discussion by:
Guest:
Michelle Buchbinder, MD
Resident – Family Medicine Residency Program
Jefferson Health – Abington
Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA.
This Podcast Episode does not offer CME/CE Credit.
Send us a text about this episode.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:
1. Brain Function Outcomes of Recent and Lifetime Cannabis Use. JAMA Network Open 2025. Discussion by:
Guest:
Maija Adourian, DO
Resident– Family Medicine Residency Program
Jefferson Health – Abington
2. Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity. New England Journal of Medicine. Discussion by:Guest:Christopher M. Kramer, MD
George A. Beller/Lantheus Medical Imaging
Distinguished Professor of Cardiovascular Medicine
Chief of the Cardiovascular Division
UVA Health
3. Screening for Osteoporosis to Prevent Fractures
US Preventive Services Task Force Recommendation Statement. Discussion by:
Guest:
Anupriya Grover-Wenk, DO
Faculty– Family Medicine Residency Program
Jefferson Health – Abington
Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA.
This Podcast Episode does not offer CME/CE Credit.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/on-the-lookout-for-eoe-9990
SummaryIn this CME/CE podcast, two gastroenterologists discuss the increasing prevalence of eosinophilic esophagitis (EoE), our evolving understanding of its pathophysiology, and its varied clinical presentation. Drs. Brooks Cash and Paul Feuerstadt also review the need for early identification of the condition, and discuss the latest American College of Gastroenterology guideline for diagnosis.
Learning ObjectiveAt the conclusion of this activity, participants should be better able to:
- Identify common clinical presentations and diagnostic challenges to facilitate early diagnosis of EoE in diverse patient populations
This activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.50 contact hours (which includes 0 hours of pharmacology).
For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.
Summary of Individual DisclosuresPlease review faculty and planner disclosures here.
Disclosure of Commercial SupportThis activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/management-approaches-for-eoe-9991
SummaryThe American College of Gastroenterology has published the first new guidelines for the treatment of eosinophilic esophagitis (EoE) since 2013. In this CME/CE podcast, Drs. Paul Feuerstadt and Brooks Cash discuss these latest recommendations, reviewing the role of proton pump inhibitors, topical steroids, diet elimination, a biologic, and esophageal dilation in the management of this increasingly recognized condition.
Learning ObjectivesAt the conclusion of this activity, participants should be better able to:
- Assess the efficacy and safety profile of approved agents for EoE, with a focus on swallowed corticosteroids, in the management of EoE
- Apply evidence-based guidelines to optimize treatment outcomes and improve the quality of life for patients with EoE
This activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.50 contact hours (which includes 0.25 hours of pharmacology).
For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.
Summary of Individual DisclosuresPlease review faculty and planner disclosures here.
Disclosure of Commercial SupportThis activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/exercise-for-mental-health-9983 SummaryWe’ve heard it time and time again, exercise is of great importance to our physical health—but did you know it is also important to our mental health? An activity as simple as taking a daily walk can have a substantial positive impact on depression outcomes. Despite the widespread benefits of exercise, patients and providers may overlook its importance in treatment plans. This presentation focuses on the mental and physical benefits of exercise, drawing insights from published data and clinical experience.
In this PsychTalk podcast/webcast episode, Dr. Gregory Mattingly and Dr. Gerald Maguire discuss the benefits of exercise on both physical and mental health. Throughout the episode, they go through the research that supports the benefits of exercise, as well as provide practical strategies to encourage your patients to adopt exercise into their lifestyles.
This podcast was recorded and is being used with permission of the presenters.
Learning ObjectivesAt the conclusion of this activity, participants should be better able to:
- Describe the impact of exercise on mental health
- Review data from prospective studies investigating the relationship between exercise and depression
This activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which does not include hours of pharmacology).
For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.
Summary of Individual DisclosuresPlease review faculty and planner disclosures here.
Disclosure of Commercial SupportThis educational activity is not commercially supported.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/psychedelics-for-depression-9984 SummaryIn this PsychTalk podcast/webcast episode, Drs. Gregory Mattingly and Gerald Maguire explore the emerging role of psychedelics in treating mental health conditions. Listeners will learn about the mechanisms of action of psychedelic therapeutics and gain insights into their effects on the brain and behavior. The program will also review recent clinical trial data on the efficacy of psychedelic treatments for major depressive disorder (MDD), as well as provide expert insights on how to discuss the future of psychedelics with patients.
This podcast was recorded and is being used with permission of the presenters.
Learning ObjectivesAt the conclusion of this activity, participants should be better able to:
- Describe the mechanism of action of psychedelic therapeutics
- Review clinical trial data regarding the use of psychedelic treatments in MDD
This activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.75 contact hours (which includes 0.75 hours of pharmacology).
For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.
Summary of Individual DisclosuresPlease review faculty and planner disclosures here.
Disclosure of Commercial SupportThis educational activity is not commercially supported.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:
1. Large Language Model GPT-4 Compared to Endocrinologist Responses on Initial Choice of Antidiabetic Medication – Diabetes Care. Discussion by:
Guest:
James Flory, M.D.
Associate Professor
in the Weill Cornell Medical College
Associate Attending at the Memorial Sloan Kettering Cancer Center.
2. Risk of dementia associated with anticholinergic drugs for overactive bladder in adults aged ≥55 years – BMJ Medicine. Discussion by:Guest:Kimberly Alfonso, MD,
Resident– Family Medicine Residency Program
Jefferson Health – Abington
3. Fluoride Exposure and Children’s IQ Scores A Systematic Review and Meta-Analysis . JAMA Pediatrics 2024. Discussion by:
Guest:
Elyssa Heisey, DO
Resident– Family Medicine Residency Program
Jefferson Health – Abington
Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA.
This Podcast Episode does not offer CME/CE Credit.
Send us a text about this episode.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/using-newer-agents-in-chronic-hyperkalemia-management-9953 SummaryIn this concise CME/CE podcast, a cardiologist and primary care physician review hyperkalemia management options that safely allow continuing GDMT for patients with heart failure or CKD. Using case examples, the clinicians provide education on individualizing treatment and addressing disparities in care.
Learning ObjectiveAt the conclusion of this activity, participants should be better able to:
- Identify practical aspects of using potassium binders for treating hyperkalemia and optimizing GDMT to achieve equitable care for patients with HF and CKD
This activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0.25 hours of pharmacology).
For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.
Summary of Individual DisclosuresPlease review faculty and planner disclosures here.
Disclosure of Commercial SupportThis educational activity is supported by an educational grant from AstraZeneca Pharmaceuticals.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/managing-the-burden-of-hyperkalemia-9952 SummaryIn this concise CME/CE podcast, a cardiologist and a family physician discuss risks associated with hyperkalemia in patients being treated for heart failure or chronic kidney disease (CKD)—including the risks that accompany down-titration or discontinuation of RAASi therapy.
Drs. Javed Butler and Neil Skolnik provide guidance on which patients are most at risk and review the use of potassium binders that can manage hyperkalemia without compromising the crucial use of guideline-directed medical therapy (GDMT). By the end of this podcast episode, listeners will feel much more confident in their ability to safely and effectively address hyperkalemia in patients with heart failure or CKD.
Learning ObjectivesAt the conclusion of this activity, participants should be better able to:
- Describe the disparities and clinical implications of hyperkalemia in patients with HF and CKD in terms of optimizing guideline-directed medical therapy (GDMT) and outcomes
- Discuss the safety and effectiveness of potassium binders in reducing potassium and optimizing GDMT in patients with HF and CKD
This activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0 hours of pharmacology).
For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.
Summary of Individual DisclosuresPlease review faculty and planner disclosures here.
Disclosure of Commercial SupportThis educational activity is supported by an educational grant from AstraZeneca Pharmaceuticals.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/tick-tock-psych-expert-tips-on-complex-patient-management-9943 SummaryMore often than not, patients present to clinicians with multiple diagnoses—complicating treatment decisions. Whether the comorbidities are related to psychiatric, cardiovascular, or neurologic etiologies, psychiatry clinicians need to know how to optimally manage patients in the face of such challenges. This presentation provides quick, to-the-point answers to audience questions regarding complex patient management.
In this PsychTalk podcast/webcast episode, Dr. Gregory Mattingly and Dr. Gerald Maguire go against the clock to answer your questions on complex patient management in the psychiatry setting. They are given 2 minutes to answer each question, packing their expertise into small, bite-sized sections.
This podcast was recorded and is being used with permission of the presenters.
Learning ObjectiveAt the conclusion of this activity, participants should be better able to:
- Discuss psychiatric management considerations for patients with complex comorbidities in your clinical practice.
This activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.75 contact hours (which includes 0.25 hours of pharmacology).
For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.
Summary of Individual DisclosuresPlease review faculty and planner disclosures here.
Disclosure of Commercial SupportThis educational activity is not commercially supported.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/breakthroughs-of-mental-health-advances-9942 SummaryWe saw a lot of changes in 2024, especially in the mental health/psychiatry space. Keeping up with the most current information and how it affects your practice can be challenging in this ever-changing landscape. This presentation aims to make this information more accessible to clinicians so that patients can receive the most up-to-date care.
In this PsychTalk podcast/webcast episode, Dr. Gregory Mattingly and Dr. Gerald Maguire wrap up 2024 with a question-and-answer session focused on the latest advances in the mental health field. Listen as they go through questions covering major depressive disorder, ADHD, bipolar disorder, and schizophrenia.
This podcast was recorded and is being used with permission of the presenters.
Learning ObjectiveAt the conclusion of this activity, participants should be better able to:
- Review the latest advances in ADHD, MDD, bipolar disorder, and schizophrenia
This activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which includes 0.50 hours of pharmacology).
For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.
Summary of Individual DisclosuresPlease review faculty and planner disclosures here.
Disclosure of Commercial SupportThis educational activity is not commercially supported.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/recognizing-atopic-dermatitis-and-prurigo-nodularis-9891
SummaryIn this concise CME/CE podcast, a dermatologist and a primary care clinician discuss atopic dermatitis and prurigo nodularis—two conditions that often present with relentless itch and can significantly affect patients’ quality of life. Listen as the two clinicians detail the influence of type 2 inflammation and inflammatory cytokines on the pathophysiology of these diseases, as well as describe their clinical manifestations across skin types. By the end of this podcast episode, listeners will feel much more confident in their ability to identify atopic dermatitis and prurigo nodularis in clinical practice.
Learning ObjectivesAt the conclusion of this activity, participants should be better able to:
- Recognize the similarities and differences in the clinical presentations, symptoms, and triggers of AD and PN, including in patients with skin of color
- Describe the role of type 2 inflammation in the pathophysiology of AD and PN
This activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which does not include hours of pharmacology).
For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.
Summary of Individual DisclosuresPlease review faculty and planner disclosures here.
Disclosure of Commercial SupportThis activity is supported by an independent medical education grant from Sanofi and Regeneron Pharmaceuticals, Inc.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/collaborative-care-in-atopic-dermatitis-and-prurigo-nodularis-9892 SummaryIn this concise CME/CE podcast, a dermatologist and primary care clinician review treatment options for patients with atopic dermatitis and prurigo nodularis. Using case examples, the clinicians provide education on individualizing treatment by evaluating patients for treatment progress, modifying treatment plans, and using shared decision-making.
Learning ObjectivesAt the conclusion of this activity, participants should be better able to:
- Develop a treatment plan for managing patients with AD and/or PN based on current guidelines and evolving clinical data, including specialty referral when appropriate
- Apply communication strategies to facilitate SDM in the management of patients with AD and PN to improve adherence and outcomes
This activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0.25 hours of pharmacology).
For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.
Summary of Individual DisclosuresPlease review faculty and planner disclosures here.
Disclosure of Commercial SupportThis activity is supported by an independent medical education grant from Sanofi and Regeneron Pharmaceuticals, Inc.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:
1. Insulin Efsitora versus Degludec in Type 2 Diabetes without Previous Insulin Treatment. Discussion by:
Guest:
Carol Wysham, M.D,
Clinical Associate Professor of Medicine
University of Washington School of Medicine
Section Head of the Department of Diabetes and Endocrinology
Rockwood Clinic in Spokane, Washington.
2. Cervical Cancer: Screening – Draft statement of the U.S. Preventive Services Task Force. Discussion by:Guest: Amy Clouse
Associate Clinical Professor
Sidney Kimmell Medical College of Thomas Jefferson University
Associate Director - Family Medicine Residency Program
Jefferson Health – Abington
3. Chocolate intake and risk of type 2 diabetes: prospective cohort studies. The British Medical Journal 2024. Discussion by:
Guest:
Elyssa Heisey, DO
Resident– Family Medicine Residency Program
Jefferson Health – Abington
Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA.
This Podcast Episode does not offer CME/CE Credit.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/adult-adhd-diagnosis-and-management-9854
SummaryAdult ADHD is a neurodevelopmental disorder that often persists from childhood into adulthood, affecting attention, impulsivity, and executive function. Despite increased awareness, ADHD in adults remains underdiagnosed and undertreated, presenting unique challenges in clinical practice. This presentation focuses on strategies to address these challenges, drawing insights from recent data and provides our experts recommendations.
In this PsychTalk podcast/webcast episode, Dr. Gregory Mattingly and Dr. Vladimir Maletic discuss key findings from the CDC report on adult ADHD, including trends in prevalence, diagnostic gaps, and barriers to effective treatment. They also explore the latest research on gender differences in ADHD, emphasizing how these disparities impact diagnosis and treatment approaches. Our experts highlight the need for tailored strategies to ensure more accurate and effective care, especially given that women are often diagnosed later in life and may experience different symptom presentations than men.
This podcast was recorded and is being used with permission of the presenters.
Learning ObjectivesAt the conclusion of this activity, participants should be better able to:
- Review key insights from the CDC report regarding the prevalence, diagnosis trends, and treatment challenges of ADHD in adults
- Examine the latest data on gender differences in ADHD diagnosis and treatment
This activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which does not include hours of pharmacology).
For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.
Summary of Individual DisclosuresPlease review faculty and planner disclosures here.
Disclosure of Commercial SupportThis educational activity is not commercially supported.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/questions-and-answers-on-amyloid-cardiomyopathy-and-polyneuropathy-9845
SummaryIn this activity – which learners can review as a podcast or a webcast - Drs. Chafic Karam and Michelle Kittleson dive into five key questions from recent live-virtual broadcasts about transthyretin amyloidosis (ATTR). They discuss the role of cardiac MRI, biopsy, and genetic testing in diagnosing ATTR cardiomyopathy and polyneuropathy. They also explore treatment options, including silencing therapies and stabilizers, with insights into when patients should be referred for specialized care. The conversation emphasizes the importance of early diagnosis, collaborative care between neurologists and cardiologists, and the expanding therapeutic landscape for ATTR.
Learning ObjectivesAt the conclusion of this activity, participants should be better able to:
- Describe the correct diagnostic algorithm for suspected ATTR, including interpretation of the monoclonal protein screen and indications for biopsy and genetic testing.
- Initiate appropriate management, including disease-directed therapy and appropriate cardiac care, or referral when indicated.
This activity is accredited for CME/CE CreditAssociation of Black Cardiologists, Inc. (ABC) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Association of Black Cardiologists, Inc. designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and ABC. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.25 contact hours (which does not include hours of pharmacology).
In support of improving patient care, this activity has been planned and implemented by Haymarket Medical Education (HME) and NACE. Haymarket Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This knowledge-based activity JA4008232-9999-24-043-H01-P qualifies for 0.25 contact hours (0.025 CEUs) of continuing pharmacy education credits.
For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.
Summary of Individual DisclosuresPlease review faculty and planner disclosures here.
Disclosure of Commercial SupportThis educational activity is supported by an educational grant from Alnylam Pharmaceuticals, Inc., and an educational grant from AstraZeneca Pharmaceuticals.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:
https://www.mycme.com/courses/streamlined-strategies-for-managing-tardive-dyskinesia-9842
SummaryTardive dyskinesia (TD) is a debilitating movement disorder that manifests as involuntary, repetitive movements, often of the face, tongue, and extremities. These symptoms frequently result from prolonged use of antipsychotic medications, particularly in patients being treated for schizophrenia, bipolar disorder, or major depressive disorder. Accurate and routine assessment of TD is critical to prevent symptom progression and improve patient outcomes. The Abnormal Involuntary Movement Scale (AIMS) is a widely accepted, gold-standard tool used to detect and measure the severity of involuntary movements. AIMS enables clinicians to detect involuntary movements early and track the disorder's progression, facilitating timely intervention and individualized treatment plans.
In this PsychTalk podcast/webcast episode, Dr. Gregory Mattingly and Dr. Vladimir Maletic delve into the complexities of diagnosing and managing tardive dyskinesia (TD), emphasizing evidence-based strategies to improve patient outcomes. They discuss the importance of using the Abnormal Involuntary Movement Scale (AIMS), a standardized and validated tool, for regular TD assessment. AIMS enables clinicians to detect involuntary movements early and track the disorder's progression, facilitating timely intervention and individualized treatment plans.
Learning ObjectiveAt the conclusion of this activity, participants should be better able to:
- Explore strategies to simplify management and optimally improve outcomes for patients with TD
This activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.75 contact hours (which includes 0.50 hours of pharmacology).
For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.
Summary of Individual DisclosuresPlease review faculty and planner disclosures here.
Disclosure of Commercial SupportThis educational activity is supported by an educational grant from Neurocrine Biosciences.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:
1. Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction. Discussion by:Guest:
Muthiah Vaduganathan, MD
Co-Director of the Center for Cardiometabolic Implementation Science
Brigham and Women’s Hospital.
2. Screen Use at Bedtime and Sleep Duration and Quality Among Youths
– JAMA Pediatrics 2024. Discussion by:Guest:
Conor Bradley MD
Resident– Family Medicine Residency Program
Jefferson Health – Abington
3. Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis . New England Journal of Medicine. Discussion by:
Guest:
Michelle Buchbinder, MD
Resident– Family Medicine Residency Program
Jefferson Health – Abington
Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA.
This Podcast Episode does not offer CME/CE Credit.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/leaky-gut-leaky-brain-addressing-gut-brain-axis-9815 SummaryThough it is widely acknowledged that the gut is our largest endocrine and immune organ, its role in brain health is less well-known. When is the last time you asked a patient with depression about their diet? Mental health care expands beyond pharmacologic treatment, as explained in this activity detailing the influence of the gut-brain axis on neuroinflammation and the role that diet and pre/probiotics can play in mental health treatment.
In this PsychTalk podcast/webcast episode, Dr. Gregory Mattingly and Dr. Vladimir Maletic discuss the gut-brain axis and its influence on brain health, from its role in the manifestation of certain brain disorders and how we can target the gut to ultimately improve patient outcomes in psychiatry.
This podcast was recorded and is being used with permission of the presenters.
Learning ObjectivesAt the conclusion of this activity, participants should be better able to:
- Identify the key mechanisms of the gut-brain axis influence on brain disorders.
- Discuss ways of incorporating understanding of gut dysbiosis into comprehensive treatment of psychiatric disorders.
This activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which does not include hours of pharmacology).
For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.
Summary of Individual DisclosuresPlease review faculty and planner disclosures here.
Disclosure of Commercial SupportThis educational activity is not commercially funded.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/management-of-amyloid-cardiomyopathy-and-polyneuropathy-9813
SummaryIn this CME/CE podcast episode, Cardiologist Dr. Michelle Kittleson and Neurologist Dr. Chafic Karam discuss the multidisciplinary management of transthyretin amyloidosis (ATTR). They explore how ATTR affects both the heart and the nervous system, focusing on recognizing symptoms, diagnosing the disease, and managing treatment. Dr. Karam shares insights on peripheral neuropathy caused by amyloidosis, including clues that suggest amyloidosis over more common neuropathies. Dr. Kittleson highlights how cardiologists assess and manage TTR cardiomyopathy, emphasizing the importance of early diagnosis and the evolving therapeutic landscape. Together, they discuss the collaborative nature of care, the impact of new therapies on clinical outcomes, and the importance of raising awareness for ATTR.
Learning Objectives
- Describe the correct diagnostic algorithm for suspected ATTR, including interpretation of the monoclonal protein screen and indications for biopsy and genetic testing
- Initiate appropriate management, including disease-directed therapy and appropriate cardiac care, or referral when indicated
This activity is accredited for CME/CE CreditAssociation of Black Cardiologists, Inc. (ABC) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Association of Black Cardiologists, Inc. designates this enduring material for a maximum of 0.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and ABC. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.25 contact hours (which does not include hours of pharmacology).
For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.
Summary of Individual DisclosuresPlease review faculty and planner disclosures here.
Disclosure of Commercial SupportThis educational activity is supported by an educational grant from Alnylam Pharmaceuticals Inc., and an educational grant from AstraZeneca Pharmaceuticals.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/vmat2-inhibitors-in-tardive-dyskinesia-9799
SummaryTardive dyskinesia (TD) is a syndrome characterized by various iatrogenic movement disorders resulting from dopamine receptor antagonism. These movement disorders include akathisia, dystonia, buccolingual stereotypy, chorea, tics, and other abnormal involuntary movements, most commonly emerging after prolonged antipsychotic use.
Vesicular monoamine transporter type 2 (VMAT2) inhibitors are now available in the United States for managing dyskinesia syndromes, each with a slightly different range of approved indications. VMAT2 inhibitors are agents that cause a depletion of neuroactive peptides such as dopamine in nerve terminals and are used to treat chorea due to neurodegenerative diseases or dyskinesias due to neuroleptic medications (tardive dyskinesia).
In this PsychTalk podcast/webcast episode, Dr. Gregory Mattingly and Dr. Vladimir Maletic discuss the structural and pharmacokinetic differences between these agents, understanding how they modulate dopamine levels at hypersensitive D2 receptors, common in TD. The program emphasizes the importance of VMAT2 inhibition and its interaction with antipsychotic medications.
This podcast was recorded and is being used with permission of the presenters.
Learning ObjectiveAt the conclusion of this activity, participants should be better able to:
- Examine the pharmacologic differences between the various VMAT2 inhibitors
This activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.75 contact hours (which includes 0.50 hours of pharmacology).
For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.
Summary of Individual DisclosuresPlease review faculty and planner disclosures here.
Disclosure of Commercial SupportThis educational activity is supported by an educational grant from Neurocrine Biosciences.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:
1. Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction. Discussion by:Guest:
Muthiah Vaduganathan, MD
Co-Director of the Center for Cardiometabolic Implementation Science
Brigham and Women’s Hospital.
2. A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening– NEJM 2024. Discussion by:Guest:
Mathew Clark, MD
Clinical Professor at the Sidney Kimmel medical college of
Thomas Jefferson University
Associate Director Family Medicine Residency Program
Jefferson Health - Abington
3. Mindfulness Meditation vs Escitalopram for Treatment of Anxiety Disorders
Secondary Analysis of a Randomized Clinical Trial. JAMA Network Open Discussion by:
Guest:
Kim Alfonzo, MD
Resident– Family Medicine Residency Program
Jefferson Health – Abington
Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA.
This Podcast Episode does not offer CME/CE Credit.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/dare-to-move-beyond-symptom-improvement-schizophrenia-9781
SummarySchizophrenia is a chronic and debilitating mental illness that significantly affects not only the health, well-being, and functioning of patients but also their surrounding environment. Promoting resilience is essential for enhancing health as well as treating mental health issues. A fresh perspective on schizophrenia emphasizes early intervention, symptom enhancement, relapse prevention, functional advancement, and quality of life improvement. The importance of personalized care to improve functional outcomes for individuals living with the condition gain insights into the DARE approach:
- Detection – The importance of early detection and intervention in reducing the burden of schizophrenia and increasing recovery chances.
- Adherence – Shared decision-making for optimal medication choice, focusing on balancing efficacy and minimizing adverse effects that can lead to nonadherence (e.g., sedation, weight gain).
- Recovery – Functional recovery, quality of life, and achieving personal life goals as key outcomes in treatment.
- Engagement – Supporting patients in leading purposeful and meaningful lives.
In this PsychTalk podcast/webcast episode, Dr. Gregory Mattingly and Dr. Vladimir Maletic discuss the DARE approach and how shifting the goals of schizophrenia treatment toward not just response and remission but full recovery and resilience, underscore a holistic approach to mental health.
Learning ObjectivesAt the conclusion of this activity, participants should be better able to:
- Evaluate the latest advancements in functional domains for schizophrenia treatment.
- Discuss personalized treatment to improve functional outcomes for individuals living with schizophrenia.
This activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which does not include hours of pharmacology).
For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.
Summary of Individual DisclosuresPlease review faculty and planner disclosures here.
Disclosure of Commercial SupportThis educational activity is not commercially funded.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:
1. Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care. JAMA 2024. Discussion by:
Guest:
Stephen Salloway, MD
Director of Neurology and the Memory and Aging Program at Butler Hospital
Professor of Psychiatry and Professor of Neurology at the
Warren Alpert Medical School of Brown University.
2. Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity - (The SURMOUNT OSA Trial) – NEJM 2024. Discussion by:Guest:
Atul Malhotra, MD
Professor of Pulmonary Critical Care & Sleep Medicine
Previous at the University of California, San Diego.
3. Relative vaccine effectiveness of high-dose vs standard-dose influenza vaccines in preventing hospitalization and mortality: A meta-analysis of the evidence. Journal of Infection July 2024. https://doi.org/10.1016/j.jinf.2024.106187 Discussion by:
Guest:
Anupriya Grover-Wenk, MD
Faculty– Family Medicine Residency Program
Jefferson Health – Abington
Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA.
This Podcast Episode does not offer CME/CE Credit.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/tackling-residual-risk-in-ascvd-and-ckd-9653
SummaryInflammation plays a pivotal role in both cardiovascular and chronic kidney disease, making it a crucial target for reducing patient risk. In this focused 15-minute podcast, our experts break down the latest insights into how inflammation drives these conditions and explore innovative approaches to managing it.
Listen to Dr. Ridker as he will delve into the critical role of inflammation in cardiovascular and chronic kidney disease, with a focus on the predictive value of hsCRP as a biomarker for ASCVD and CKD risk. Dr. Ridker explores emerging strategies to address inflammation, and how these advancements could potentially reduce cardiovascular risk and improve patient outcomes.
Learning ObjectiveAt the conclusion of this activity, participants should be better able to:
- Recognize the role of hsCRP as a biomarker in evaluating the risk of ASCVD and CKD
- Identify the role of current and emerging agents, based on their mechanism of action, to target inflammation and potentially reduce cardiovascular risk
This activity is accredited for CME/CE CreditAssociation of Black Cardiologists, Inc. (ABC) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Association of Black Cardiologists, Inc. designates this enduring material for a maximum of 0.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and ABC. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which includes 0.25 hours of pharmacology).
For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.
Summary of Individual DisclosuresPlease review faculty and planner disclosures here.
Disclosure of Commercial SupportThis educational activity is supported by an independent medical educational grant from Novo Nordisk.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/circling-the-wagons-to-care-fibrosing-ilds-9649
SummaryNavigating the challenges of fibrosing ILDs requires a team approach. In this podcast, explore the "Dream Team" of healthcare professionals who collaborate to address the diverse needs of patients with IPF, SSc-ILD, and PPF. From pulmonologists to therapists and beyond, uncover the critical roles each plays in managing comorbidities, symptoms, and overall well-being. Gain valuable insights on when to refer to a specialized ILD center for comprehensive care.
Learning ObjectiveAt the conclusion of this activity, participants should be better able to:
- Integrate multidisciplinary management for patients with fibrosing ILDs to manage comorbidities and monitor for the need for specialty center referral
This activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours, which includes 0 hours of pharmacology.
For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.
Summary of Individual DisclosuresPlease review faculty and planner disclosures here.
Disclosure of Commercial SupportThis activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/major-depressive-disorder-interventions-for-remission-9634
SummaryThe goal of treating major depressive disorder (MDD) is complete remission. Unfortunately, residual symptoms, such as anhedonia and cognitive impairment, are common in patients with MDD and contribute to worse outcomes. Tailoring antidepressant therapy to individual patients can help to mitigate residual symptoms and promote complete remission.
In this PsychTalk podcast/webcast episode, Dr. Gregory Mattingly and Dr. Vladimir Maletic discuss the risk-benefit profiles of available antidepressants and their efficacy for residual depressive symptoms. The faculty review the relative burden of side effects with different agents, the impact of therapies on cognitive function, and specific approaches to managing anhedonia.
This podcast/webcast was recorded and is being used with permission of the presenters.
Learning ObjectivesAt the conclusion of this activity, participants should be better able to:
- Discuss the risk–benefit profile of antidepressant medications and the potential impact on residual symptoms
- Tailor MDD interventions to specific patient needs, based on the presence or risk of residual symptoms and using culturally sensitive communication, to achieve clinical remission
This activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.75 contact hours (which includes 0.50 hours of pharmacology).
For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.
Summary of Individual DisclosuresPlease review faculty and planner disclosures here.
Disclosure of Commercial SupportThis educational activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/primary-care-questions-on-moderate-to-severe-asthma-9617 SummaryTwo experts from distinct clinical backgrounds – a primary care physician and a pulmonology PA – answer the top 5 questions primary care clinicians have about moderate-to-severe asthma. These questions come from clinician learners at Conversations in Primary Care (CPC) and Emerging Challenges and Clinical Updates in Primary Care (ECCU) live-virtual symposia from May through August, 2024.
In just 15 minutes, this podcast/webcast covers the latest on:
- New inhaler options: Albuterol/budesonide and smart therapy alternatives
- Montelukast: Weighing benefits against risks and boxed warnings
- Biomarkers: What to test and how to use the results to guide referrals
- Biologics: When to consider them and how to co-manage with specialists
- Practical tips: Best practices for primary care clinicians in everyday asthma management
Learning ObjectivesUpon completion of this activity, learners should be able to:
- Evaluate patients with asthma to identify those with inflammatory phenotypes who are more likely to have exacerbations and severe disease
- Escalate care for patients with moderate-to-severe asthma uncontrolled on ICS-LABA
This activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours, which includes 0.25 hours of pharmacology.
For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.
Summary of Individual DisclosuresPlease review faculty and planner disclosures here.
Disclosure of Commercial SupportThis activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:
1. Physician Coaching by Professionally Trained Peers for Burnout and Well-Being. Jama Open Network 2024
Guest:
Susan Kuchera, MD
Program Director – Family Medicine Residency Program
Jefferson Health – Abington
2. Association of Semaglutide With Tobacco Use Disorder in Patients With Type 2 Diabetes/ Target Trial Emulation Using Real-World Data/ Annals of Internal MedicineGuest:
Richard Potter, MD
Resident – Family Medicine Residency Program
Jefferson Health – Abington
3. Counterfit Ozempic JAMA
Guest:
Jasmine Walker, MD
Resident – Family Medicine Residency Program
Jefferson Health – Abington
Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA.
This Podcast Episode does not offer CME/CE Credit.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:
1. Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer’s disease: a randomized, controlled clinical trial. Alzheimer’s Research & Therapy https://doi.org/10.1186/s13195-024-01482-z (2024) 16:122
Guest:
Philip Lieberman, MD
Resident – Family Medicine Residency Program
Jefferson Health – Abington
2. Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 DiabetesGuest:
Richard E. Pratley , MD
Medical Director at the AdventHealth Diabetes Institute
Senior Investigator, Diabetes Program Lead at the Translational Research Institute
3. Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver FibrosisGuest:
Richard Potter, MD
Resident – Family Medicine Residency Program
Jefferson Health – Abington
Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA.
This Podcast Episode does not offer CME/CE Credit.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/impacting-copd-outcomes-challenges-and-opportunities-9534
SummaryJoin Dr. Fernando Martinez as he welcomes Dr. David Au and Dr. Jamuna Krishnan to The NACE Clinical Highlights Show. This podcast highlights the research of Dr. Au and Dr. Krishnan, discussing the important translation of their research into pulmonology clinical practice.
Learning ObjectivesAt the conclusion of this activity, participants should be better able to:
- Identify ways to overcome provider and practice-based healthcare disparities in the management of patients with COPD
This activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours, which includes 0 hours of pharmacology.
For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.
Summary of Individual DisclosuresPlease review faculty and planner disclosures here.
Disclosure of Commercial SupportThis activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc and Sanofi.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/dd5-your-questions-on-menopausal-vasomotor-symptoms-9542
SummaryDr. Leana Wen guides Dr. Genevieve Neal-Perry through five of your most common questions on menopausal VMS. Get a better understanding of the evolution in the science surrounding the biology of menopause, and discuss new and emerging non-hormonal treatment options for women with menopausal hot flashes and night sweats. Keep the conversation going with this, the third podcast in the series.
Learning ObjectivesUpon completion of this activity, learners should be able to:
- Discuss the biology of menopausal vasomotor symptoms (VMS)
- Integrate new and emerging agents into the treatment of women with menopausal VMS, based on patient characteristics and preferences
This activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours, which includes 0 hours of pharmacology.
For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.
Summary of Individual DisclosuresPlease review faculty and planner disclosures here.
Disclosure of Commercial SupportThis educational activity is supported by an independent medical educational grant from Astellas Pharma Global Development, Inc.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/a-better-understanding-advances-in-severe-asthma-9530
SummaryIn this CME/CE podcast, join NACE and the Association for Pulmonary Advanced Practice Providers as Nurse Practitioner Corinne Young and Dr. Diego Maselli take a deep dive into the latest advances in severe asthma treatment. Join in a dynamic discussion on groundbreaking research into IL-13 agents and mucus production, TSLP, mast cell activity, and more. Discover the experts’ take on the latest evolutions in our understanding of asthma treatments, and gain practical insights into how these innovations are shaping clinical practice.
Learning Objectives
Upon completion of this activity, learners should be able to:
- Review evolving concepts in the understanding, evaluation, and treatments of severe asthma and their implications on management
This activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours, which includes 0 hours of pharmacology.
For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.
Summary of Individual DisclosuresPlease review faculty and planner disclosures here.
Disclosure of Commercial SupportThis activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/recognizing-the-burden-of-residual-symptoms-in-mdd-9526
SummaryEarly and effective treatment of major depressive disorder (MDD) is essential to prevent persistent residual symptoms, which are associated with worse outcomes. Evidence indicates that residual symptoms, such as impaired cognition, are underrecognized and undertreated in routine clinical care. Recognizing residual symptoms and the factors contributing to suboptimal treatment response is a critical first step to modifying management, with the goal of eliminating residual symptoms and achieving full remission.
In this PsychTalk podcast/webcast episode, Dr. Gregory Mattingly and Dr. Vladimir Maletic discuss common residual symptoms and other signs of suboptimal treatment response, including the impact of antidepressant side effects and the efficacy of antidepressants for residual symptoms.
This podcast/webcast was recorded and is being used with permission of the presenters.
This activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.75 contact hours (which includes 0.25 hours of pharmacology).
For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.
Summary of Individual DisclosuresPlease review faculty and planner disclosureshere.
Disclosure of Commercial Support
This educational activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:
https://www.mycme.com/courses/answering-your-questions-on-lipids-and-risk-9498
SummaryThere’s no shortage of information on the management of lipids for the prevention of cardiovascular disease:
- 2018 Guideline on the Management of Blood Cholesterol.
- 2022 ACC Expert Consensus Decision Pathway.
- CLEAR Outcomes, CVOT studies, Risk Calculators.
Helping sort these and other topics out, Dr. James Underberg and Dr. Jessica Pena discuss the top 5 learner submitted questions/topics from the recent programs on non-statin lipid management in primary prevention of ASCVD.
This activity is accredited for CME/CE CreditAssociation of Black Cardiologists, Inc. (ABC) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Association of Black Cardiologists, Inc. designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and ABC. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.25 contact hours (which includes 0 hours of pharmacology).
For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.
Summary of Individual DisclosuresPlease review faculty and planner disclosures here.
Disclosure of Commercial SupportThis educational activity is supported in part by an educational grant from Esperion Therapeutics, Inc. and an independent educational grant from Novartis Pharmaceuticals Corporation.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/dd5-your-questions-on-cytokines-in-asthma-9477 SummaryIn this activity, moderator Corinne Young works with asthma expert Amanda Michaud to answer the common and remaining questions regarding inflammation in asthma, the role of TSLP and other alarmins, and the modulation of upstream and downstream cytokines with available and emerging biologic agents for asthma. Five questions in fifteen minutes – can they do it?!
Learning Objectives
Upon completion of this activity, learners should be able to:
- Discuss the role of epithelial cytokines in the inflammatory response of asthma and other airway diseases
- Select appropriate agents to target the ongoing inflammatory cascade in patients with severe asthma
This activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hour (which includes 0 hours of pharmacology).
For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.
Summary of Individual DisclosuresPlease review faculty and planner disclosures here.
Disclosure of Commercial SupportThis educational activity is supported by an independent educational grant from AstraZeneca Pharmaceuticals.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
NACE is excited to provide you with this podcast episode from our educational collaborator, The Association of Pulmonary Advanced Practice Providers (APAPP). APAPP is the first association of Advanced Practice Providers (APPs), both Nurse Practitioners and Physician Assistants, who work in the field of pulmonary medicine. APAPP's mission is to work together for the advancement of the profession and for the well-being of patients with pulmonary diseases. To learn more about APAPP and to get involved, please visit https://www.pulmapp.com.
Host
Corinne R. Young, MSN, FNP-C, FCCP
Director of APP and Clinical Services, Colorado Springs Pulmonary Consultants
President, APAPP, Colorado Springs, CO
Corinne Young is a Nurse Practitioner began working in the area of pulmonary disease in California in 2005. Since 2011, she has worked in a private pulmonary practice in Colorado Springs, Colorado. Involvement and the representation of advanced practice providers in the pulmonary world has been an important priority for Corinne. To that end, Corinne is the Founder and President of the Association of Pulmonary Advanced Practice Providers.
In addition to her work with APAPP, Corinne is currently one of ten NPs nationwide to become a Fellow of the American College of Chest Physicians. She works closely with the American College of Chest Physicians CHEST programs, and serves on the Interprofessional Team Network, Clinical Research Network, and on the Executive Programing Committee. Additionally, Corinne serves on the American Board of Internal Medicine Pulmonary Disease Board.
This Podcast episode does not offer CME/CE Credit.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/new-approaches-to-menopausal-vms-9462 SummaryThis CME podcast explores the latest advancements in managing menopausal vasomotor symptoms (VMS). Join Dr. Genevieve Neil-Perry as she discusses the biology of VMS, highlighting the role of KNDy neurons and neurokinin B. Discuss evidence-based treatments, including the new NK3 receptor antagonists and their clinical data. Gain practical insights into tailoring treatment to individual patient needs and addressing the unique challenges faced by women entering menopause.
Learning Objectives
Upon completion of this activity, learners should be able to:
- Discuss the biology of menopausal VMS
- Integrate new and emerging agents into the treatment of women with menopausal VMS, based on patient characteristics and preferences
This activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.50 contact hours (which includes 0.25 hours of pharmacology).
For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.
Summary of Individual DisclosuresPlease review faculty and planner disclosures here.
Disclosure of Commercial SupportThis educational activity is supported by an independent medical educational grant from Astellas Pharma Global Development, Inc.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/exploring-the-depths-of-resilience-9449 Summary
Resilience, the ability to bounce back from adversity, is not solely determined by genetic factors but is heavily influenced by epigenetic mechanisms. Epigenetics can then influence DNA gene expression, playing a crucial role in shaping our resilience. It is known that while genetics provide a blueprint, our experiences and lifestyle choices can determine how those genes are expressed. However, neuroplasticity, the brain's remarkable ability to reorganize and adapt, underscores the potential for resilience to be cultivated and strengthened throughout life.
In this podcast/webcast episode, Dr. Gregory Mattingly and Dr. Vladimir Maletic discuss the impact of resilience as well as strategies such as cognitive-behavioral therapy, exercise, social support networks, and healthy lifestyle habits which have been shown to promote neuroplasticity and enhance resilience by positively impacting epigenetic processes. By understanding and leveraging these interconnected concepts, individuals can empower themselves to navigate life's challenges with greater resilience and adaptability.
This podcast was recorded and is being used with permission of the presenters.
Learning Objectives
Upon completion of this activity, learners should be able to:
- Summarize how trauma and resilience impact epigenetics and neuroplasticity
- Discuss clinical interventions and strategies to improve resilience within your practice
This activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which does not include any hours of pharmacology).
For additional information about the accreditation of this program, contact NACE at info@naceonline.com.
Summary of Individual DisclosuresPlease review faculty and planner disclosures here. Disclosure of Commercial Support
This educational activity is not commercially supported.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/how-to-manage-stress-mood-and-hormones-9448 Summary
Hormonal changes play a significant role in influencing mood and cognition. Fluctuations in hormone levels can impact neurotransmitter activity and neural circuits associated with mood regulation and cognitive function. For instance, during menstruation, pregnancy, menopause, and times of stress, hormone levels can fluctuate, leading to mood swings, irritability, anxiety, and cognitive changes.
In this podcast/webcast episode, Dr. Gregory Mattingly and Dr. Vladimir Maletic discuss the impact of stress, hormones and mood, as understanding these hormonal influences is crucial for managing mood disorders, improving cognitive function, and promoting overall well-being.
This podcast was recorded and is being used with permission of the presenters.
Learning Objectives
Upon completion of this activity, learners should be able to:
- Summarize the role of hormonal changes and their impact on mood and cognition
- Discuss recent developments that improve outcomes of hormonally triggered problems with mood or cognition
This activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which does not include any hours of pharmacology).
For additional information about the accreditation of this program, contact NACE at info@naceonline.com. Summary of Individual DisclosuresPlease review faculty and planner disclosures here. Disclosure of Commercial Support
This educational activity is not commercially supported.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
NACE is excited to provide you with this podcast episode from our educational collaborator, The Association of Pulmonary Advanced Practice Providers (APAPP). APAPP is the first association of Advanced Practice Providers (APPs), both Nurse Practitioners and Physician Assistants, who work in the field of pulmonary medicine. APAPP's mission is to work together for the advancement of the profession and for the well-being of patients with pulmonary diseases. To learn more about APAPP and to get involved, please visit https://www.pulmapp.com.
Guest
Tyler Kuhk, MNNurse Practitioner
Overlake Medical Center & Clinics - Pulmonary Medicine
Bellevue, Washington.
Tyler Kuhk is an Adult-Gerontology Nurse Practitioner at Overlake Medical Center & Clinics – Pulmonary Medicine in Bellevue, Washington. He attended Lakehead University in Thunder Bay, Ontario, Canada where he obtained his Bachelor of Science in Nursing Degree in 2010. During his undergraduate studies he was the President of the Lakehead University Nursing Association (LUNA) and later became heavily involved in the Canadian Nursing Students’ Association (CNSA) where he served as Ontario Regional Director (2007-2008) and as President (2008-2009). As President he was also a board member of both the Canadian Nurses Association (CNA) and Canadian Federation of Nurses Unions (CFNU). Tyler began his career at the Thunder Bay Regional Health Sciences Centre (TBRHSC) as a Medical-Surgical Registered Nurse, specializing in orthopedics and cardiac-telemetry. He also worked casually in a long-term care facility where he continued to foster an appreciation for gerontology. When the opportunity presented itself to relocate to the Pacific Northwest, Tyler transitioned into the critical care environment for the next six years, practicing in Tacoma, Everett and Bellevue, mainly in the cardiovascular ICU setting. In 2013 he decided to embark on a new journey within nursing and started his Master of Nursing Degree at the University of Toronto in the Adult-Gerontology Nurse Practitioner stream. During his studies he trained in a variety of settings including inpatient cardiology, inpatient internal medicine and outpatient pulmonology. He graduated in November 2015 and began practicing in outpatient pulmonology in April 2016. His main areas of clinical interest include chronic cough, chronic obstructive pulmonary disease and asthma.
Host
Corinne R. Young, MSN, FNP-C, FCCP
Director of APP and Clinical Services, Colorado Springs Pulmonary Consultants
President, APAPP, Colorado Springs, CO
Corinne Young is a Nurse Practitioner began working in the area of pulmonary disease in California in 2005. Since 2011, she has worked in a private pulmonary practice in Colorado Springs, Colorado. Involvement and the representation of advanced practice providers in the pulmonary world has been an important priority for Corinne. To that end, Corinne is the Founder and President of the Association of Pulmonary Advanced Practice Providers.
In addition to her work with APAPP, Corinne is currently one of ten NPs nationwide to become a Fellow of the American College of Chest Physicians. She works closely with the American College of Chest Physicians CHEST programs, and serves on the Interprofessional Team Network, Clinical Research Network, and on the Executive Programing Committee. Additionally, Corinne serves on the American Board of Internal Medicine Pulmonary Disease Board.
This Podcast episode does not offer CME/CE Credit.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/candid-conversations-about-menopause-treatment-barriers-9387 SummaryJoin Dr. Genevieve Neil-Perry as she moderates a dynamic panel discussion on the obstacles hindering access to quality menopause treatment. Dr. Gregg Sherman (primary care) and Dr. Nanette Santoro (OB/GYN) bring their clinical perspectives, while a patient joins and shares their firsthand experiences.
This episode explores the unique challenges faced by patients and providers within the menopause care landscape. The panel delves into potential solutions, aiming to empower listeners with knowledge and strategies to overcome these barriers for improved menopause care.
Learning Objective
- Identify patient and clinician barriers to management of menopausal symptoms
This activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which does not include hours of pharmacology ).
For additional information about the accreditation of this program, contact NACE at info@naceonline.com.
Summary of Individual DisclosuresAngela Golden has disclosed the following financial relationships:
- Consultant: Novo Nordisk (obesity), Lilly (obesity), Acella (thyroid), Currax (obesity), Boehringer Ingelheim (obesity), WW (obesity), Gelesis (obesity - relationship has ended)
- Speaker: Novo Nordisk (obesity), Lilly (obesity), Acella (thyroid), Currax (obesity)
- Receipt of Royalty: Springer (obesity - relationship has ended), Amazon (fiction)
Guest Patient has no relevant financial relationships to disclose.
Bernadette Makar has no relevant financial relationships to disclose.
Gregg Sherman has no relevant financial relationships to disclose.
Genevieve Neal-Perry has disclosed the following financial relationships:
- Scientific Advisory Board: Astellas (women’s health), Natera (women’s health)
- Review Panel: SRI (professional organization)
Nanette Santorohas disclosed the following financial relationships:
- Consultant: Astellas Pharma, MenoGeniX, Ansh Labs
- All disclosures are related to women's health.
All of the relevant financial relationships listed for these individuals have been mitigated. Faculty, planners, guest patient(s) (if applicable), and moderators for this educational activity not listed in the Summary of Individual Disclosures above have no relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Disclosure of Commercial SupportThis educational activity is supported by an independent medical educational grant from Astellas Pharma Global Development, Inc.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:
1. Aspirin and Cardiovascular Risk in Individuals With Elevated Lipoprotein(a)Guest:
Brad Rivotto, MD
Resident – Family Medicine Residency Program
Jefferson Health – Abington
2. Triple – Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
Julio Rosenstock, MD
Senior Scientific Advisor for Velocity Clinical Research,
Director of Velocity’s site at Medical City Dallas,
Clinical Professor of Medicine at the University of Texas Southwestern Medical Center, Dallas.
3. Healthy weight loss maintenance with exercise, GLP-1 receptor agonist, or both combined followed by one year without treatment: a post-treatment analysis of a randomised placebo-controlled trial.
Amrin Syed, DO
Resident – Family Medicine Residency Program
Jefferson Health – Abington
Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA.
This Podcast Episode does not offer CME/CE Credit.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
NACE is excited to provide you with this podcast episode from our educational collaborator, The Association of Pulmonary Advanced Practice Providers (APAPP). APAPP is the first association of Advanced Practice Providers (APPs), both Nurse Practitioners and Physician Assistants, who work in the field of pulmonary medicine. APAPP's mission is to work together for the advancement of the profession and for the well-being of patients with pulmonary diseases. To learn more about APAPP and to get involved, please visit https://www.pulmapp.com.
Guest
Cori Fratelli, RN, MSN, FNP-CNurse Practitioner
Division of Pulmonary, Critical Care & Sleep Medicine
Department of Medicine
I have a unique background in both basic science and clinical research, which has informed my interest in clinical medicine. My past basic science research includes asthma, airway hyperresponsiveness, cystic fibrosis, and lung cancer. My past clinical research includes COPD and interstitial lung disease (ILD). Presently, I am interested in how research translates into personalized medicine. My clinical focus is mainly ILD, but I also see general pulmonary medicine patients, as needed.
Host
Corinne R. Young, MSN, FNP-C, FCCP
Director of APP and Clinical Services, Colorado Springs Pulmonary Consultants
President, APAPP, Colorado Springs, CO
Corinne Young is a Nurse Practitioner began working in the area of pulmonary disease in California in 2005. Since 2011, she has worked in a private pulmonary practice in Colorado Springs, Colorado. Involvement and the representation of advanced practice providers in the pulmonary world has been an important priority for Corinne. To that end, Corinne is the Founder and President of the Association of Pulmonary Advanced Practice Providers.
In addition to her work with APAPP, Corinne is currently one of ten NPs nationwide to become a Fellow of the American College of Chest Physicians. She works closely with the American College of Chest Physicians CHEST programs, and serves on the Interprofessional Team Network, Clinical Research Network, and on the Executive Programing Committee. Additionally, Corinne serves on the American Board of Internal Medicine Pulmonary Disease Board.
This Podcast episode does not offer CME/CE Credit.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:
1. Long-Term Leisure-Time Physical Activity Intensity and All-Cause and Cause-Specific Mortality: A Prospective Cohort of US AdultsGuest:
Philip Lieberman, MD,
Resident – Family Medicine Residency Program
Jefferson Health – Abington
2. Association between changes in carbohydrate intake and long term weight changes: prospective cohort study
Walter C. Willett, M.D., Dr. P.H.
Professor of Epidemiology and Nutrition at Harvard T.H. Chan School of Public Health,
Professor of Medicine, Harvard Medical School
3. Clinically Important Benefits and Harms of Monoclonal Antibodies Targeting Amyloid for the Treatment of Alzheimer Disease: A Systematic Review and Meta-Analysis
Richard Potter, MD, Resident – Family Medicine Residency Program
Jefferson Health – Abington
Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA.
This Podcast Episode does not offer CME/CE Credit.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
Show NotesNACE is excited to provide you with this podcast episode from our educational collaborator, The Association of Pulmonary Advanced Practice Providers (APAPP). APAPP is the first association of Advanced Practice Providers (APPs), both Nurse Practitioners and Physician Assistants, who work in the field of pulmonary medicine. APAPP's mission is to work together for the advancement of the profession and for the well-being of patients with pulmonary diseases. To learn more about APAPP and to get involved, please visit https://www.pulmapp.com.
Guest
Cori Fratelli, RN, MSN, FNP-CNurse Practitioner
Division of Pulmonary, Critical Care & Sleep Medicine
Department of Medicine
I have a unique background in both basic science and clinical research, which has informed my interest in clinical medicine. My past basic science research includes asthma, airway hyperresponsiveness, cystic fibrosis, and lung cancer. My past clinical research includes COPD and interstitial lung disease (ILD). Presently, I am interested in how research translates into personalized medicine. My clinical focus is mainly ILD, but I also see general pulmonary medicine patients, as needed.
Host
Corinne R. Young, MSN, FNP-C, FCCP
Director of APP and Clinical Services, Colorado Springs Pulmonary Consultants
President, APAPP, Colorado Springs, CO
Corinne Young is a Nurse Practitioner began working in the area of pulmonary disease in California in 2005. Since 2011, she has worked in a private pulmonary practice in Colorado Springs, Colorado. Involvement and the representation of advanced practice providers in the pulmonary world has been an important priority for Corinne. To that end, Corinne is the Founder and President of the Association of Pulmonary Advanced Practice Providers.
In addition to her work with APAPP, Corinne is currently one of ten NPs nationwide to become a Fellow of the American College of Chest Physicians. She works closely with the American College of Chest Physicians CHEST programs, and serves on the Interprofessional Team Network, Clinical Research Network, and on the Executive Programing Committee. Additionally, Corinne serves on the American Board of Internal Medicine Pulmonary Disease Board.
This Podcast episode does not offer CME/CE Credit.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:
1. Strategies to Increase Cervical Cancer Screening With Mailed Human Papillomavirus Self-Sampling Kits: A Randomized Clinical TrialGuest:
Amy Clouse, MD
Associate Director
Family Medicine Residency
Jefferson Health – Abington.
2. Association Between Changes in Carbohydrate Intake and Long Term Weight Changes: Prospective Cohort StudyGuest:
Walter C. Willett, MD, PhD
Professor of Epidemiology and Nutrition
Harvard T.H. Chan School of Public Health
3. Guidelines of care for the management of atopic dermatitis in adults with topical therapies – Journal of the American Academy of DermatologyGuest:
Catherine McCormick, DO
Resident in the Family Medicine Residency
Jefferson Health – Abington.
Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA.
This Podcast Episode does not offer CME/CE Credit.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:
1. Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial –
The New England Journal of Medicine
Guest:
Marrisa Norden, DO
Resident
Family Medicine Residency
Jefferson Health-Abington, Abington, PA
2. Muvalaplin, an Oral Small Molecule Inhibitor of Lipoprotein(a) Formation A
Randomized Clinical Trial - JAMA
Guest:
Richard Potter, MD
Resident
Family Medicine Residency
Jefferson Health-Abington, Abington, PA
3. Sedentary Behavior and Incident Dementia Among Older Adults - JAMA
Guest:
Michael Devano, DO
Resident
Family Medicine Residency
Jefferson Health-Abington, Abington, PA
Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA.
This Podcast Episode does not offer CME/CE Credit.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/answering-questions-about-homozygous-familial-hypercholesterolemia-9140Featuring faculty Zahid Ahmad, MD, FNLA, and Don Wilson, MD
SummaryHomozygous familial hypercholesterolemia (FH) is a rare but critical genetic disorder characterized by extremely high LDL cholesterol levels, significantly increasing the risk of early cardiovascular disease. In this activity, Dr. Zahid Ahmad and Dr. Don Wilson provide expert insights into homozygous FH, answering questions from recent live-virtual symposia. They cover crucial topics, including diagnosis, pediatric lipid screening, genetic testing, and care coordination. The experts emphasize the significance of specialized care and early intervention for individuals with homozygous FH, aiming to better inform healthcare professionals and improve patient outcomes.
Learning ObjectivesUpon completion of this activity, learners should be able to:
- Diagnose HoFH based on clinical criteria and genetic testing when indicated
- Implement, or refer patients for, cascade screening and the appropriate pharmacologic treatment of HoFH
- Recognize and address patient and family needs to overcome barriers to care in HoFH
This activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which include 0 hours of pharmacology).
Click on the link to view the summary of individual disclosures.https://www.naceonline.com/courses/deep-dive-into-five-answering-your-questions-about-hofh
Disclosure of Commercial Support
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
Show NotesNACE is excited to provide you with this podcast episode from our educational collaborator, The Association of Pulmonary Advanced Practice Providers (APAPP). APAPP is the first association of Advanced Practice Providers (APPs), both Nurse Practitioners and Physician Assistants, who work in the field of pulmonary medicine. APAPP's mission is to work together for the advancement of the profession and for the well-being of patients with pulmonary diseases. To learn more about APAPP and to get involved, please visit https://www.pulmapp.com.
Guest
Susan Wilxon, MD Dr. Susan Wilcox, M.D., attended medical school at Washington University School of Medicine and trained in Emergency Medicine in the Harvard Affiliated Emergency Medicine Residency, graduating in 2008. After residency, she completed an Anesthesia Critical Care fellowship at Massachusetts General Hospital. Since finishing her training in 2009, she divided her time between the Emergency Department and critical care, working in Surgical ICUs, Medical ICUs, and long-term vent units. In July 2017, she assumed the role of the Chief of the newly formed Division of Critical Care within the Department of Emergency Medicine MGH. In addition to attending in the Emergency Department, she also attends in the Heart Center ICU and serves as the Associate Chief Medical Officer of Boston MedFlight.
Host
Corinne R. Young, MSN, FNP-C, FCCP
Director of APP and Clinical Services, Colorado Springs Pulmonary Consultants
President, APAPP, Colorado Springs, CO
Corinne Young is a Nurse Practitioner began working in the area of pulmonary disease in California in 2005. Since 2011, she has worked in a private pulmonary practice in Colorado Springs, Colorado. Involvement and the representation of advanced practice providers in the pulmonary world has been an important priority for Corinne. To that end, Corinne is the Founder and President of the Association of Pulmonary Advanced Practice Providers.
In addition to her work with APAPP, Corinne is currently one of ten NPs nationwide to become a Fellow of the American College of Chest Physicians. She works closely with the American College of Chest Physicians CHEST programs, and serves on the Interprofessional Team Network, Clinical Research Network, and on the Executive Programing Committee. Additionally, Corinne serves on the American Board of Internal Medicine Pulmonary Disease Board.
This Podcast episode does not offer CME/CE Credit.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/using-glp-1-ras-to-reduce-cv-risk-in-t2d-9134
SummaryType 2 diabetes (T2D) doubles a patient’s risk for atherosclerotic cardiovascular disease (ASCVD), which is the leading cause of morbidity and mortality in patients with T2D. The 2023 ADA guidelines now recommend consideration of GLP-1 RAs in patients with T2D and ASCVD or indicators of ASCVD risk, independently of A1C and metformin use. In this episode, Dr. Pam Taub reviews recent updates in the cardiovascular benefits and appropriate use of GLP-1 receptor agonists for managing patients with T2D.
Learning Objectives
- Incorporate early use of GLP-1 RA therapy in appropriate patients with T2D using a holistic approach, considering administration route and optimal dosing
- Overcome barriers to GLP-1 RA uptake and medication adherence in T2D through patient counseling to manage adverse effects
This activity is accredited for CME/CE CreditAssociation of Black Cardiologists, Inc. (ABC) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Association of Black Cardiologists, Inc. (ABC) designates this enduring material for a maximum of 0.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and ABC. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.25 contact hours (which includes 0.25 hours of pharmacology).
For additional information about the accreditation of this program, contact NACE at info@naceonline.com.
Summary of Individual Disclosures
Dr. Taub financial relationships:
Consultant: Amgen, Bayer, Boehringer Ingelheim, Novartis, Novo Nordisk, Esperion, Merck, Sanofi, Medtronic
Contracted Research: Amgen, Novartis
All her disclosures are related to cardiology
Dr. Morris financial relationships:
Consultant and advisor: Acorai, Regeneron, Merck
Speaker: Abbott, BI Lilly, Cytokinetics, Edwards Lifesciences, Ionis
Contracted Research: Boston Scientific, Cytokinetics, Ionis, Merck, Myokardia, Novartis
Stocks: Gilead Sciences
All her disclosures are related to heart failure.
All of the relevant financial relationships listed for these individuals have been mitigated.
Association of Black Cardiologists Planning Committee
Tierra Dillenburg has no relevant conflicts of interest with any ACCME-defined commercial interest.
Faculty, planners, guest patient(s) (if applicable), and moderators for this educational activity not listed in the Summary of Individual Disclosures above have no relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Disclosure of Commercial SupportThis educational activity is supported by an independent educational grant from Novo Nordisk Inc.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
Show NotesNACE is excited to provide you with this podcast episode from our educational collaborator, The Association of Pulmonary Advanced Practice Providers (APAPP). APAPP is the first association of Advanced Practice Providers (APPs), both Nurse Practitioners and Physician Assistants, who work in the field of pulmonary medicine. APAPP's mission is to work together for the advancement of the profession and for the well-being of patients with pulmonary diseases. To learn more about APAPP and to get involved, please visit https://www.pulmapp.com.
Guest
Martha Kingman, FNP-C, DNP Family Nurse Practitioner in the pulmonary hypertension clinic at the University of Texas Southwestern Medical Center at Dallas.
She is presently serving as sub-investigator in numerous ongoing pulmonary hypertension clinical trials. She is a member of the speakers’ bureaus for Actelion, United Therapeutics, and Gilead, and she gives her time and expertise to several nursing advisory boards. Martha is an active member of the PH Professional Network, having previously served on the national conference planning committee, and she has chaired the Research and Publications Committee of the Pulmonary Hypertension Association. She currently serves on the Editorial Board of Advances in Pulmonary Hypertension, the PHA’s journal.
Dr. Kingman earned a bachelor’s degree from Tulsa University School of Nursing in Tulsa, following which she worked in emergency department settings as a staff nurse and then as director of the ED after which she obtained her Master of Science in Nursing degree from Texas Woman’s University in Dallas. When she became board certified as a Family Nurse Practitioner, she accepted the job of nurse practitioner in the pulmonary department at UTSW Medical Center and remains in that role today. The majority of her clinical work involves the follow-up outpatient care of a large group of pulmonary hypertension patients at UTSW Medical Center. In May 2011, Dr. Kingman obtained her Doctorate in Nursing Practice from Texas Christian University.
Martha has published in the area of pulmonary hypertension and has spoken at local and national conferences. Her main area of research interest involves the safety of intravenous prostacyclins in the hospital setting.
Host
Corinne R. Young, MSN, FNP-C, FCCP
Director of APP and Clinical Services, Colorado Springs Pulmonary Consultants
President, APAPP, Colorado Springs, CO
Corinne Young is a Nurse Practitioner began working in the area of pulmonary disease in California in 2005. Since 2011, she has worked in a private pulmonary practice in Colorado Springs, Colorado. Involvement and the representation of advanced practice providers in the pulmonary world has been an important priority for Corinne. To that end, Corinne is the Founder and President of the Association of Pulmonary Advanced Practice Providers.
In addition to her work with APAPP, Corinne is currently one of ten NPs nationwide to become a Fellow of the American College of Chest Physicians. She works closely with the American College of Chest Physicians CHEST programs, and serves on the Interprofessional Team Network, Clinical Research Network, and on the Executive Programing Committee. Additionally, Corinne serves on the American Board of Internal Medicine Pulmonary Disease Board.
This Podcast episode does not offer CME/CE Credit.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
Show NotesNACE is excited to provide you with this podcast episode from our educational collaborator, The Association of Pulmonary Advanced Practice Providers (APAPP). APAPP is the first association of Advanced Practice Providers (APPs), both Nurse Practitioners and Physician Assistants, who work in the field of pulmonary medicine. APAPP's mission is to work together for the advancement of the profession and for the well-being of patients with pulmonary diseases. To learn more about APAPP and to get involved, please visit https://www.pulmapp.com.
Guest
Rebecca Prebe, Nurse Practitioner
Host
Corinne R. Young, MSN, FNP-C, FCCP
Director of APP and Clinical Services, Colorado Springs Pulmonary Consultants
President, APAPP, Colorado Springs, CO
Corinne Young is a Nurse Practitioner began working in the area of pulmonary disease in California in 2005. Since 2011, she has worked in a private pulmonary practice in Colorado Springs, Colorado. Involvement and the representation of advanced practice providers in the pulmonary world has been an important priority for Corinne. To that end, Corinne is the Founder and President of the Association of Pulmonary Advanced Practice Providers.
In addition to her work with APAPP, Corinne is currently one of ten NPs nationwide to become a Fellow of the American College of Chest Physicians. She works closely with the American College of Chest Physicians CHEST programs, and serves on the Interprofessional Team Network, Clinical Research Network, and on the Executive Programing Committee. Additionally, Corinne serves on the American Board of Internal Medicine Pulmonary Disease Board.
This Podcast episode does not offer CME/CE Credit.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
Show Notes
NACE is excited to provide you with this podcast episode from our educational collaborator, The Association of Pulmonary Advanced Practice Providers (APAPP). APAPP is the first association of Advanced Practice Providers (APPs), both Nurse Practitioners and Physician Assistants, who work in the field of pulmonary medicine. APAPP's mission is to work together for the advancement of the profession and for the well-being of patients with pulmonary diseases. To learn more about APAPP and to get involved, please visit https://www.pulmapp.com.
Guest
Joanne Wozniak HudsonNeed more information here..... Can't find bio online.
Host
Corinne R. Young, MSN, FNP-C, FCCP
Director of APP and Clinical Services, Colorado Springs Pulmonary Consultants
President, APAPP, Colorado Springs, CO
Corinne Young is a Nurse Practitioner began working in the area of pulmonary disease in California in 2005. Since 2011, she has worked in a private pulmonary practice in Colorado Springs, Colorado. Involvement and the representation of advanced practice providers in the pulmonary world has been an important priority for Corinne. To that end, Corinne is the Founder and President of the Association of Pulmonary Advanced Practice Providers.
In addition to her work with APAPP, Corinne is currently one of ten NPs nationwide to become a Fellow of the American College of Chest Physicians. She works closely with the American College of Chest Physicians CHEST programs, and serves on the Interprofessional Team Network, Clinical Research Network, and on the Executive Programing Committee. Additionally, Corinne serves on the American Board of Internal Medicine Pulmonary Disease Board.
This Podcast episode does not offer CME/CE Credit.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
Show Notes
All is not as it seems? Dr. Alain Eid’s passion for research and years of experience as a principal investigator on innumerable studies helps us learn how to pick apart research articles and not to take them at face value. Take a deeper dive and strengthen your knowledge in evidence based medicine.
NACE is excited to provide you with this podcast episode from our educational collaborator, The Association of Pulmonary Advanced Practice Providers (APAPP). APAPP is the first association of Advanced Practice Providers (APPs), both Nurse Practitioners and Physician Assistants, who work in the field of pulmonary medicine. APAPP's mission is to work together for the advancement of the profession and for the well-being of patients with pulmonary diseases. To learn more about APAPP and to get involved, please visit https://www.pulmapp.com.
Guest
Alain Eid, MD
Alain Eid, MD is a 1991 graduate from St. Joseph University Medical School (Lebanon). He received his Medical school training in the hospitals of Paris, France. He completed his residency in Internal Medicine at St. John Hospital, Detroit. He finished his fellowship in Pulmonary Medicine and Critical Care at the Oklahoma University Medical Center. He was appointed Associate Professor of Pulmonary and Critical Care Medicine from 1998 through 2004 at the Oklahoma University. He is board Certified in Critical Care, Pulmonary Medicine and Sleep Medicine. Dr. Eid has a special interest and vast experience in lung cancer diagnosis and management. He developed the Lung nodule Clinic/ Lung cancer center at the VA of Oklahoma City. Once in Colorado Springs, he championed the development of the lung Cancer Center at Memorial Hospital and then at Penrose Hospital.
Host
Corinne R. Young, MSN, FNP-C, FCCP
Director of APP and Clinical Services, Colorado Springs Pulmonary Consultants
President, APAPP, Colorado Springs, CO
Corinne Young is a Nurse Practitioner began working in the area of pulmonary disease in California in 2005. Since 2011, she has worked in a private pulmonary practice in Colorado Springs, Colorado. Involvement and the representation of advanced practice providers in the pulmonary world has been an important priority for Corinne. To that end, Corinne is the Founder and President of the Association of Pulmonary Advanced Practice Providers.
In addition to her work with APAPP, Corinne is currently one of ten NPs nationwide to become a Fellow of the American College of Chest Physicians. She works closely with the American College of Chest Physicians CHEST programs, and serves on the Interprofessional Team Network, Clinical Research Network, and on the Executive Programing Committee. Additionally, Corinne serves on the American Board of Internal Medicine Pulmonary Disease Board.
This Podcast episode does not offer CME/CE Credit.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
Show Notes
This episode is packed full of recommendations to help you make the most of your visits with your COPD patients.Nurse Practitioner Alanna Kavanaugh, who works with the American Lung Association’s COPD Advisory Board and has been part of the international GOLD Guideline updates Joins Corinne to discuss guidelines and best practices in the management of your COPD patients.
NACE is excited to provide you with this podcast episode from our educational collaborator, The Association of Pulmonary Advanced Practice Providers (APAPP). APAPP is the first association of Advanced Practice Providers (APPs), both Nurse Practitioners and Physician Assistants, who work in the field of pulmonary medicine. APAPP's mission is to work together for the advancement of the profession and for the well-being of patients with pulmonary diseases. To learn more about APAPP and to get involved, please visit https://www.pulmapp.com.
Guest
Alanna Kavanaugh, EdD(c), FNP-BC, MSN, BSN, CCRN
Alanna Kavanaugh is a Board certified Family Nurse Practitioner. She received her master’s degree from the College of Mount Saint Vincent. She is currently pursuing her Doctorate of Nursing Education at Columbia University, Teachers College. She is a Graduate Program Chair and Director of the Family Nurse Practitioner Program at her alma mater, the College of Mount Saint Vincent. Under her leadership, she has restructured the curriculum to improve student outcomes and created several innovative programs to improve student success. Her work improved Board Certification Rates above 90% for first time test takers. Her innovative programs provide a strong clinical foundation for the world’s future clinicians and her programs aid in smooth student transition to practice.
Host
Corinne R. Young, MSN, FNP-C, FCCP
Director of APP and Clinical Services, Colorado Springs Pulmonary Consultants
President, APAPP, Colorado Springs, CO
Corinne Young is a Nurse Practitioner began working in the area of pulmonary disease in California in 2005. Since 2011, she has worked in a private pulmonary practice in Colorado Springs, Colorado. Involvement and the representation of advanced practice providers in the pulmonary world has been an important priority for Corinne. To that end, Corinne is the Founder and President of the Association of Pulmonary Advanced Practice Providers.
In addition to her work with APAPP, Corinne is currently one of ten NPs nationwide to become a Fellow of the American College of Chest Physicians. She works closely with the American College of Chest Physicians CHEST programs, and serves on the Interprofessional Team Network, Clinical Research Network, and on the Executive Programing Committee. Additionally, Corinne serves on the American Board of Internal Medicine Pulmonary Disease Board.
This Podcast episode does not offer CME/CE Credit.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/itch-scratch-immunotherapies-for-prurigo-nodularis-8912Featuring faculty Shawn Kwatra, MD, moderated by Gregg Sherman, MD
Summary
Prurigo nodularis (PN) is a chronic inflammatory skin disease characterized by severe, unrelenting pruritus that is higher in intensity and associated with greater decrease in quality of life than with other pruritic dermatoses such as atopic dermatitis and psoriasis.
In this second of two podcast episodes, Dr. Shawn Kwatra and Dr. Gregg Sherman discuss the pathophysiology of PN and how to incorporate recently approved and emerging therapies into the management of this condition.
This podcast was recorded and is being used with the permission of the presenters.
Learning Objectives
Upon completion of this activity, learners should be able to:
- Describe the role of neuroimmune dysregulation in the pathophysiology of PN
- Individualize therapy for patients with PN based on the best available evidence, including recent clinical trial data
This activity is accredited for CME/CE Credit.The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0.25 hours of pharmacology).
Summary of Individual DisclosuresAngela Golden has disclosed the following financial relationships:
- Consultant: SetPoint (obesity), WW (obesity)
- Advisor: Currax (obesity), Genesis (obesity), Lilly (obesity), Novo Nordisk (obesity), Acela (hypothyroidism)
- Speaker: Currax (obesity), Novo Nordisk (obesity)
- Receipt of Royalty: Amazon (fiction books), Springer (obesity book)
Shawn Kwatra has disclosed the following financial relationships:
- Advisory board member and is a consultant for Abbvie (atopic dermatitis), Amgen (atopic dermatitis), Arcutis Biotherapeutics (psoriasis), Aslan Pharmaceuticals (atopic dermatitis), Cara Therapeutics (atopic dermatitis), Castle Biosciences (melanoma), Celldex Therapeutics (prurigo nodularis), Galderma (prurigo nodularis), Genzada Pharmaceuticals (eczema), Incyte Corporation (eczema, prurigo nodularis), Johnson & Johnson (eczema), Leo Pharma (eczema), Novartis Pharmaceuticals Corporation (psoriasis), Pfizer (atopic dermatitis), Regeneron Pharmaceuticals (atopic dermatitis) , and Sanofi (atopic dermatitis, prurigo)
- Served as an investigator for Galderma (prurigo nodularis), Incyte Corporation (eczema, prurigo nodularis), Pfizer (atopic dermatitis), and Sanofi (atopic dermatitis, prurigo)
Faculty, planners, guest patient(s) (if applicable), and moderators for this educational activity not listed in the Summary of Individual Disclosures above have no relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/itching-scratching-diagnosing-prurigo-nodularis-8910Featuring faculty Shawn Kwatra, MD, moderated by Gregg Sherman, MD.
SummaryPrurigo nodularis (PN) is a chronic inflammatory skin disease characterized by severe, unrelenting pruritus that is higher in intensity and associated with greater decrease in quality of life (QoL) than with other pruritic dermatoses such as atopic dermatitis and psoriasis.
In this first of two podcast episodes, Dr. Shawn Kwatra and Dr. Gregg Sherman discuss the presentation and diagnosis of PN.
This podcast was recorded and is being used with the permission of the presenters.
This CME/CE podcast is available for credit on myCME.
Learning Objective
Upon completion of this activity, learners should be able to:
- Identify the clinical manifestations and differential workup associated with the accurate, timely diagnosis of prurigo nodularis (PN)
This activity is accredited for CME/CE Credit.The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0 hours of pharmacology).
Summary of Individual DisclosuresAngela Golden has disclosed the following financial relationships:
- Consultant: SetPoint (obesity), WW (obesity)
- Advisor: Currax (obesity), Genesis (obesity), Lilly (obesity), Novo Nordisk (obesity), Acela (hypothyroidism)
- Speaker: Currax (obesity), Novo Nordisk (obesity)
- Receipt of Royalty: Amazon (fiction books), Springer (obesity book)
Shawn Kwatra has disclosed the following financial relationships:
- Advisory board member and is a consultant for Abbvie (atopic dermatitis), Amgen (atopic dermatitis), Arcutis Biotherapeutics (psoriasis), Aslan Pharmaceuticals (atopic dermatitis), Cara Therapeutics (atopic dermatitis), Castle Biosciences (melanoma), Celldex Therapeutics (prurigo nodularis), Galderma (prurigo nodularis), Genzada Pharmaceuticals (eczema), Incyte Corporation (eczema, prurigo nodularis), Johnson & Johnson (eczema), Leo Pharma (eczema), Novartis Pharmaceuticals Corporation (psoriasis), Pfizer (atopic dermatitis), Regeneron Pharmaceuticals (atopic dermatitis), and Sanofi (atopic dermatitis, prurigo)
- Served as an investigator for Galderma (prurigo nodularis), Incyte Corporation (eczema, prurigo nodularis), Pfizer (atopic dermatitis), and Sanofi (atopic dermatitis, prurigo)
Faculty, planners, guest patient(s) (if applicable), and moderators for this educational activity not listed in the Summary of Individual Disclosures above have no relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Disclosure of Commercial Support
This educational activity is supported by an
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
Dr. Mylynda Massart answers the top 5 questions asked by learners during her New Tools for Early Cancer Detection in Primary Care lecture. Topics addressed include patient eligibility for the test, the role of MCEDs relative to traditional cancer screening, and the status of insurance coverage.
Relevant Links
New Tools for Early Cancer Detection in Primary Care: A Primer on Blood-Based Multi-Cancer Screening https://exchangecme.com/MCEDPCPResources
Multi-Cancer Early Detection in Primary Care: What You Need to Know About New Blood-Based Screening Tools https://exchangecme.com/MCEDNACEOnline
Flexing Your Early Cancer Detection Muscles: Strengthening Your Knowledge of Blood-Based Screening Tools https://exchangecme.com/MCEDcircuit
This podcast is not accredited for CME/CE credit.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
Show Notes
What it’s like to be part of an APP fellowship program? Vincent DeRienzo, Physician Associate and Assistant Director of the APP Critical Care Medicine Fellowship Program at the Univ of Rochester walks us thought their fellowship program development, processes, successes and lessons they’ve learned along the way.
NACE is excited to provide you with this podcast episode from our educational collaborator, The Association of Pulmonary Advanced Practice Providers (APAPP). APAPP is the first association of Advanced Practice Providers (APPs), both Nurse Practitioners and Physician Assistants, who work in the field of pulmonary medicine. APAPP's mission is to work together for the advancement of the profession and for the well-being of patients with pulmonary diseases. To learn more about APAPP and to get involved, please visit https://www.pulmapp.com.
Guest
Vincent DeRienzo
Vincent DeRienzo graduated from the Daemen College Physician Assistant program. Vincent does research in Critical Care Medicine, Advanced Practice Provider Education, Psychiatry, Emergency Medicine and Health Psychology. His most recent publication is 'Depression symptomology groups among middle and older adult emergency department patients'.
Host
Corinne R. Young, MSN, FNP-C, FCCP
Director of APP and Clinical Services, Colorado Springs Pulmonary Consultants
President, APAPP, Colorado Springs, CO
Corinne Young is a Nurse Practitioner began working in the area of pulmonary disease in California in 2005. Since 2011, she has worked in a private pulmonary practice in Colorado Springs, Colorado. Involvement and the representation of advanced practice providers in the pulmonary world has been an important priority for Corinne. To that end, Corinne is the Founder and President of the Association of Pulmonary Advanced Practice Providers.
In addition to her work with APAPP, Corinne was one of the first ten NPs nationwide to become a Fellow of the American College of Chest Physicians. She works closely with the American College of Chest Physicians CHEST programs and serves on Networks, has participated on the Executive Programing Committee, and is on the Editorial Board of Chest Physician Magazine. Additionally, Corinne serves on the American Board of Internal Medicine’s Pulmonary Disease Board.
This Podcast does not offer CME/CE Credit,
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:www.Featuring faculty George Bakris, MD, moderated by Gregg Sherman, MD.
Summary
Hyperkalemia is a common condition in certain patient populations and can increase risks for hospitalizations and mortality, especially when potassium levels are not monitored appropriately. Furthermore, incorporating traditional treatment approaches for managing hyperkalemia have significant challenges, especially in high-risk patients.
In this podcast episode, Dr. George Bakris and Dr. Gregg Sherman discuss the causes, risk factors, and consequences of hyperkalemia, as well as traditional treatment approaches and their limitations.
This podcast was recorded and is being used with the permission of the presenters.
This CME/CE podcast is available for credit on myCME. Click the button on the right to listen now.
Learning Objectives
Upon completion of this activity, learners should be able to:
- Recognize the chronic nature of hyperkalemia and its causes, risk factors, and consequences
- Discuss the management of hyperkalemia, including the challenges of dietary and traditional treatment approaches
This activity is accredited for CME/CE Credit.The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0 hours of pharmacology).
Summary of Individual Disclosures
George Bakris: has disclosed the following financial relationships:
- Consultant: Bayer (Diabetic Kidney Disease), KBP BioSciences (Hypertension), Ionis (Hypertension), Alnylam (Hypertension), AstraZeneca (Hyperkalemia), Novo Nordisk (Diabetic Kidney Disease), Janssen (Hypertension), inRegen (Kidney Disease)
- Contracted Research: KBP BioSciences (Hypertension)
Angela Golden has disclosed the following financial relationships:
- Consultant: SetPoint (Obesity), WW (Obesity)
- Advisor: Currax (Obesity), Genesis (Obesity), Lilly (Obesity), Novo Nordisk (Obesity), (Obesity), Acela (Hypothyroidism)
- Speaker: Currax, Novo Nordisk (Obesity)
- Receipt of Royalty: Amazon (fiction books), Springer (obesity book)
Faculty, planners, guest patient(s) (if applicable), and moderators for this educational activity not listed in the Summary of Individual Disclosures above have no relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Disclosure of Commercial Support
This educational activity is supported by an independent educational grant from AstraZeneca Pharmaceuticals.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:www.Featuring faculty George Bakris, MD, moderated by Gregg Sherman, MD.
Summary
Hyperkalemia is a common condition in certain patient populations and can increase risks for hospitalizations and mortality. The limitations of traditional treatment approaches make management of high-risk patients challenging, particularly in those with chronic kidney disease (CKD), heart failure (HF), and hypertension. However, new and emerging treatment options are available for the management of hyperkalemia and may improve outcomes in these patients.
In this podcast episode, Dr. George Bakris and Dr. Gregg Sherman discuss new and emerging treatment options for the management of hyperkalemia, and how to incorporate these therapies most effectively for patients with CKD, HF, and hypertension.
This podcast was recorded and is being used with the permission of the presenters.
This CME/CE podcast is available for credit on myCME. Click the button on the right to listen now.
Learning Objectives
Upon completion of this activity, learners should be able to:
- Incorporate current and emerging therapies into the management of hyperkalemia in patients with CKD, HF, and hypertension based on recent clinical trial data
This activity is accredited for CME/CE Credit.The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0.25 hours of pharmacology).
Summary of Individual Disclosures
George Bakris: has disclosed the following financial relationships:
- Consultant: Bayer (Diabetic Kidney Disease), KBP BioSciences (Hypertension), Ionis (Hypertension), Alnylam (Hypertension), AstraZeneca (Hyperkalemia), Novo Nordisk (Diabetic Kidney Disease), Janssen (Hypertension), inRegen (Kidney Disease)
- Contracted Research: KBP BioSciences (Hypertension)
Angela Golden has disclosed the following financial relationships:
- Consultant: SetPoint (Obesity), WW (Obesity)
- Advisor: Currax (Obesity), Genesis (Obesity), Lilly (Obesity), Novo Nordisk (Obesity), (Obesity), Acela (Hypothyroidism)
- Speaker: Currax, Novo Nordisk (Obesity)
- Receipt of Royalty: Amazon (fiction books), Springer (obesity book)
Faculty, planners, guest patient(s) (if applicable), and moderators for this educational activity not listed in the Summary of Individual Disclosures above have no relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Disclosure of Commercial Support
This educational activity is supported by an independent educational grant from AstraZeneca Pharmaceuticals.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
NACE is excited to provide you with this podcast episode from our educational collaborator, The Association of Pulmonary Advanced Practice Providers (APAPP). APAPP is the first association of Advanced Practice Providers (APPs), both Nurse Practitioners and Physician Assistants, who work in the field of pulmonary medicine. APAPP's mission is to work together for the advancement of the profession and for the well-being of patients with pulmonary diseases. To learn more about APAPP and to get involved, please visit https://www.pulmapp.com.
Show Notes
PA Anne Cartwright isn't called the "PAP Guru" for nothing. In this episode she will walk you through how to help your sleep apnea patients get compliant with CPAP therapy. Listen in and learn how to trouble shoot common CPAP roadblocks and how to set your patients up for success. Visit www.pulmapp.com for more sleep apnea content information.
Guest
Ann Cartwright, MPAS, PA-C
Ann Cartwright is currently working as a Physician Assistant/Instructor Division of Pulmonary, Critical Care, and Sleep Medicine at the University of Colorado School of Medicine. She completed her education at the University of New England. Her clinical interests are Sleep Medicine, Lung and Breathing, Obstructive Sleep Apnea, Respiratory system, Cardiovascular system, Nervous system, and Insomnia.
Host
Corinne R. Young, MSN, FNP-C, FCCP
Director of APP and Clinical Services, Colorado Springs Pulmonary Consultants
President, APAPP, Colorado Springs, CO
Corinne Young is a Nurse Practitioner began working in the area of pulmonary disease in California in 2005. Since 2011, she has worked in a private pulmonary practice in Colorado Springs, Colorado. Involvement and the representation of advanced practice providers in the pulmonary world has been an important priority for Corinne. To that end, Corinne is the Founder and President of the Association of Pulmonary Advanced Practice Providers.
In addition to her work with APAPP, Corinne is currently one of ten NPs nationwide to become a Fellow of the American College of Chest Physicians. She works closely with the American College of Chest Physicians CHEST programs, and serves on the Interprofessional Team Network, Clinical Research Network, and on the Executive Programing Committee. Additionally, Corinne serves on the American Board of Internal Medicine Pulmonary Disease Board.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:
-
Comparative Effectiveness of Digital Cognitive Behavioral Therapy vs Medication Therapy Among Patients With Insomnia – JAMA Network OpenGuest:
Aaron Sutton
Clinical Assistant Professor of Family and Community Medicine at Thomas Jefferson University and the Behavioral Health Faculty at the Family Medicine Residency program at Abington Jefferson Health
Chief Wellness Officer for graduate medical education at Abington Jefferson Health, Abington, PA. -
Vitamin D and Risk for Type 2 Diabetes in People With Prediabetes: A Systematic Review and Meta- analysis of Individual Participant Data From 3 Randomized Clinical TrialsGuest:
Anastassios G Pittas, MD,
Professor of Internal Medicine
Tufts School of Medicine
Boston, MA -
Comparison of seven popular structured dietary programmes and risk of mortality and major cardiovascular events in patients at increased cardiovascular risk: systematic review and network meta-analysis
Guest:
Gabriella Petrongolo, DO,
Second Year Resident
Family Medicine Residency
Jefferson Health-Abington, Abington, PA -
Dietary sugar consumption and health: umbrella reviewGuest:
Richard Potter, MD,
First Year Resident,
Family Medicine Residency
Jefferson Health-Abington, PA
Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA.
This Podcast Episode does not offer CME/CE Credit.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
Welcome to the NACE Journal Club, where each month we discuss some of the most important recent articles to come out in the medical literature. This month Dr. Skolnik and guests will be discussing:
Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients The New England Journal of Medicine March 4, 2023
Dr. James Underberg who is a Clinical Assistant Professor of Medicine
in the Division of General Internal Medicine at NYU Medical School, a board
certified lipidologist and a Past president of the National Lipid Association.
Non-occupational physical activity and risk of cardiovascular disease, cancer, and mortality outcomes: a dose–response meta-analysis of large prospective studies - British Journal of Sports Medicine
Dr. Bill Callahan who is a Associate Director in the family medicine
residency program at Jefferson Health – Abington.
Lecanemab in Early Alzheimer’s Disease - New England Journal of MedicineDr. Meera Shah who is an Associate Director in the family medicine residency program at Jefferson Health – Abington and director of the geriatric curriculum
Two-year follow-up of patients with post-COVID-19 condition in Sweden: a prospective cohort study
Dr. Byce Eng who is a second year resident in the family medicine residency program at Jefferson Health – Abington.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
The NACE Journal Club with Dr. Neil Skolnik, is a new series of episodes that provide review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:
- Aspirin or Low-Molecular-Weight Heparin for Thromboprophylaxis after a Fracture Major Extremity Trauma Research Consortium (METRC), N Engl J Med 2023; 388:203-213
Guest: Marissa Norden, DO, 2nd year resident Jefferson Health Abington - Long-term Weight Training and Mortality in U.S. Male Health Professionals With and Without Type 2 Diabetes Dong Hoon Lee et.al.;Diabetes Care 2023;46(1):138–148
Guest: Matt Rubin, MD, attending physician at Main Line Health - Effect of Calorie-Unrestricted Low-Carbohydrate, High-Fat Diet Versus High-Carbohydrate, Low- Fat Diet on Type 2 Diabetes and Nonalcoholic Fatty Liver Disease Ann Intern Med. 2023 Jan;176(1):I18. doi: 10.7326/P22-0022. Epub 2022 Dec 13.
Guest: Gabriella Petrongolo, DO, 2nd year resident Jefferson Health Abington - Associations of Physical Inactivity and COVID-19 Outcomes - American Journal of Preventive Medicine Young DR, Sallis JF, Baecker A, Cohen DA, Nau CL, Smith GN, Sallis RE.;Am J Prev Med. 2022 Dec 10:S0749-3797(22)00526-8. doi: 10.1016/j.amepre.2022.10.007. Epub ahead of print.
Guest: Alex Fierstein, DO, 3rd year resident Jefferson Health Abington
Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
In this episode, Dr. Neil Skolnik and Dr. Leana S. Wen discuss addressing unmet needs in the management of COVID-19. They will discuss the importance of layering mitigation and protection strategies for those who are most at risk, along with the role of long-acting monoclonal antibodies for COVID-19 pre-exposure prophylaxis with emphasis on patients who are immunocompromised and may not respond to vaccination, in light of evolving variants.
This episode is part three of a three part series that examines the use of tixagevimab and cilgavimab for pre-exposure prophylaxis of COVID-19.
Funds for this activity have been provided by AstraZeneca.
This activity does not offer CME/CE credit
Faculty:
Neil Skolnik, MD
Professor of Family and Community Medicine
Sidney Kimmel Medical College
Thomas Jefferson University
Associate Director
Family Medicine Residency Program
Abington Jefferson Health
Philadelphia, PA
Leana S. Wen, MD, MSc
Professor, Health Policy and Management
Distinguished Fellow, Fitzhugh Mullan Institute for
Health Workforce Equity
George Washington University School of Public Health
Washington, DC
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
The NACE Journal Club with Dr. Neil Skolnik, is a new series of episodes that provide review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:
1. The protective effect of exercise against Covid infection and hospitalization in individuals vaccinated against covid, Association between regular physical activity and the protective effect of vaccination against SARS-CoV-2 in a South African case–control study. Collie S, et al. Br J Sports Med
2022;0:1–7. doi:10.1136/bjsports-2022-105734
Guest: Connie Jiang, MD is chief resident in the family medicine residency at Jefferson-Abington Health, Abington Hospital, Abington, PA
2. Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction. Solomon, et.al. N Engl J Med 2022; 387:1089-1098
DOI: 10.1056/NEJMoa2206286Guest: Orly Vardeny, Pharm.D is a BPS Board Certified clinical pharmacist with current research that focuses on novel therapies in the treatment of heart failure and the impact of influenza vaccination on heart disease. She has over 10 years of experience researching the effects of medications on cardiovascular conditions. Dr. Varney is a Core Investigator at the Center for Care Delivery and Outcomes Research, United States Department of Veterans Affairs, Associate Professor of Medicine, University of Minnesota Medical School, and Adjunct Faculty, University of Minnesota College of Pharmacy.
- Mindfulness-Based Stress Reduction vs Escitalopram for the Treatment of Adults With Anxiety Disorders: A Randomized Clinical Trial. Hoge EA, et al, JAMA Psychiatry. 2023 Jan 1;80(1):13-21. doi: 10.1001/jamapsychiatry.2022.3679.Guest: Bridget Smith, MD is a second-year resident in the family medicine residency at Jefferson Health – Abington, Abington Hospital, Abington, PA
4. Empagliflozin in Patients with Chronic Kidney Disease. The EMPA-KIDNEY Collaborative Group, N Engl J Med 2023; 388:117-127
DOI: 10.1056/NEJMoa2204233
Guest: Katie McKormick, MD is a second year resident in the family medicine residency at Jefferson Health – Abington, Abington Hospital, Abington, PA
Medical Director and Host: Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
In this episode, Dr. Neil Skolnik and Dr. Myron J. Levine discuss the use of long-acting monoclonal antibodies for COVID-19 pre-exposure prophylaxis. They explore the challenges and opportunities primary care clinicians and specialists face identifying appropriate patients to receive this treatment, with emphasis on patients who are immunocompromised and may not respond to vaccination.
This episode is part two of a three part series that examines the use of tixagevimab and cilgavimab for pre-exposure prophylaxis of COVID-19.
This podcast episode is sponsored by AstraZeneca.
This activity does not offer CME/CE credit
Faculty:
Neil Skolnik, MD
Professor of Family and Community Medicine
Sidney Kimmel Medical College
Thomas Jefferson University
Associate Director
Family Medicine Residency Program
Abington Jefferson Health
Philadelphia, PA
Myron J. Levine, MD
Associate Director, Pediatric HIV Clinic
Professor, Pediatrics-Infectious Diseases
University of Colorado Anschutz Medical Campus School of Medicine
Aurora, CO
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
In this episode, Dr. Neil Skolnik and Dr. Amy Clouse discuss the use of long-acting monoclonal antibodies for COVID-19 pre-exposure prophylaxis. They explore the challenges and opportunities primary care clinicians and specialists face identifying appropriate patients to receive this treatment, with emphasis on patients who are immunocompromised and may not respond to vaccination.
This episode is part one of a three part series that examines the use of tixagevimab and cilgavimab for pre-exposure prophylaxis of COVID-19.
This podcast episode is sponsored by AstraZeneca.
This activity does not offer CME/CE credit
Faculty:
Neil Skolnik, MD
Professor of Family and Community Medicine
Sidney Kimmel Medical College
Thomas Jefferson University
Associate Director
Family Medicine Residency Program
Abington Jefferson Health
Philadelphia, PA
Amy Clouse, MD, FAAFP
Clinical Associate Professor of Family and Community Medicine
Sidney Kimmel Medical College
Thomas Jefferson University
Associate Director
Family Medicine Residency Program
Abington Jefferson Health
Philadelphia, PA
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
In this episode. Ms. Ashlyn Smith, P.A., 2022 AAPA Physician Assistant of the Year, Endocrinology, answers questions about current topics in hyperthyroidism and clinical considerations for the diagnosis and treatment of patients with hyperthyroidism.
This session was originally recorded live on November 5, 2022 at the NACE Emerging Challenges and Clinical Updates in Primary Care Virtual Symposium.
This Episode does not offer CME/CE credit.
FacultyAshlyn Smith, MMS, PA-CAdult Endocrine PAPresident, American Society of Endocrine Physician AssistantsAdjunct Assistant Professor, Midwestern University, Glendale, AZPhoenix, AZ
Moderator
Gregg Sherman, MD
Chief Medical Officer
National Association for Continuing Education
Plantation, FL
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.naceonline.com/courses/deep-dive-into-oab-in-the-elderly-your-questions-answered
Summary
In this activity, Dr. Matt Rosenberg takes a deeper dive evaluation and management of OAB in elderly patients. Dr Rosenberg answers the five most commonly asked questions by clincians during recent presentations on Overactive Bladder (OAB) at NACE live virtual symposia
Learning Objectives
Upon completion of this activity, learners should be able to:
- Identify lower urinary tract symptoms (LUTS) and the differential diagnosis in elderly patients.
- Contrast clinically relevant differences between currently available agents for OAB.
- Individualize the management of OAB in elderly patients based on their comorbidities, medical needs, and living environment.
Moderator:
Gregg Sherman, MD
Chief Medical Officer
National Association for Continuing Education
Plantation, FL
Faculty:
Matt T. Rosenberg, MD
Director, Mid-Michigan Health Centers
Jackson, MI
This activity is accredited for CME/CE Credit.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit: https://www.naceonline.com/courses/deep-dive-into-oab-in-the-elderly-your-questions-answered
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credits™.Physicians should claim only the credit commensurate with the extent of their participation in the activity.
National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 Contact hours (which includes 0 hours of pharmacology).
This educational activity is supported by an educational grant from Urovant Sciences, Inc.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit: https://www.naceonline.com/courses/considerations-in-the-approach-to-obesity-management
Featuring speaker Robert Kushner, MD, moderated by Gregg Sherman, MD.
Summary
Obesity is a chronic disease, the care of which starts in the primary care office. However, it's an intricate diagnosis that can sometimes feel too big to take on in a primary care visit. In this podcast, Dr. Robert Kushner, an obesity management specialist, and NACE Chief Medical Officer and Family Physician, Dr. Gregg Sherman, discuss the disease of obesity, its diagnosis, and aspects of management that can make addressing obesity within your patients a little less daunting.
This podcast was recorded and is being used with the permission of the presenters.
Learning Objective
Upon completion of this activity, learners should be able to:
- Recognize obesity as a chronic, relapsing disease with unique, distinct pathophysiology that contributes to adiposity, comorbidities, and complications.
- Develop individualized treatment plans for patients with obesity that incorporate evidence-based and clinical practice guidelines.
**This activity is accredited for CME/CE Credit.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:** https://www.naceonline.com/courses/considerations-in-the-approach-to-obesity-management
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.50 contact hours (which includes 0 hours of pharmacology).
The "Considerations in the Approach to Obesity Management", offered has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for up to 0.50 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
This activity is part of the Obesity Management in Primary Care Training and Certificate Program provided by the National Association for Continuing Education (NACE) and the American Academy of Physician Associates (AAPA) in collaboration with The Obesity Society (TOS).
This educational activity is supported by an independent educational grant from Novo Nordisk Inc.
Podcast Series Title: The 411 on a GLP-1
Podcast Series Description: Join series host Dr. Jim Gavin, Clinical Professor of Medicine at Emory University and Chief Medical Officer for Healing our Village in Atlanta, Georgia, and fellow leaders in the field of diabetes as they tackle some of the challenges we face when treating T2D. Topics of discussion include clinical inertia, as well as the mechanism of action, dosing, efficacy, and safety of a GLP-1 RA for adults with T2D.
Episode Title: How to Empower Patients with T2D Knowledge and Introduce a GLP-1 RA
Episode Description: What do you need to know about a once-daily GLP-1 RA and what can you do to help your patients taking this T2D therapy? Join this multidisciplinary discussion with Jim Gavin, MD; Curtis Triplitt, PharmD; and Jeffrey Unger, MD, as they review the mechanism of action, dosing, efficacy, and safety of a once-daily GLP-1 RA for adult patients with T2D.
This program is intended for clinicians. The information presented is aligned with the views and opinions of the speakers and is sponsored by Novo Nordisk. This podcast is not to be used as medical advice and is intended for educational purposes only.Faculty Presenters:
James R. Gavin III, MD, PhD
Clinical Professor of Medicine, Emory University
Chief Medical Officer, Healing Our Village, Inc.
Atlanta, Georgia
Jeff Unger, MD, FAAFP, FACE
Diplomate, American Board of Family Practice
Assistant Clinical Professor of Family Medicine, UC Riverside School of Medicine
Riverside, California
Director, Unger Concierge Primary Care Medical Group
Rancho Cucamonga, California
Curtis L. Triplitt, PharmD, CDCES, FADCES
Clinical Associate Professor of Medicine Division of Diabetes
University of Texas Health at San Antonio
Texas Diabetes Institute, part of the University Health System
San Antonio, Texas
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit: https://www.naceonline.com/courses/glp-1-ra-a-powerful-tool-for-risk-reduction-in-diabetesFeaturing speaker Javier Morales, MD, FACP, FACE, moderated by Gregg Sherman, MD.
Summary
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a class of therapies used for the treatment of patients with type 2 diabetes (T2D). However, the role of GLP-1 RA therapy continues to evolve and expands beyond glycemic control for these patients, and includes cardiorenal protective effects. Recently updated clinical practice guidelines now recommend treatment with GLP-1 RA therapy that has demonstrated benefit in cardiovascular risk reduction in all patients with T2D.
In this podcast episode, Dr. Javier Morales and Dr. Gregg Sherman discuss strategies for selecting optimal GLP-1 RA, the early initiation of GLP-1 RA therapy in appropriate patients, and improved adherence through adverse event management.
This podcast was recorded and is being used with the permission of the presenters.
Learning Objective
Upon completion of this activity, learners should be able to:
- Select GLP-1 RA therapy for early use in appropriate patients with T2DM, based on current guidelines, patient characteristics, and evolving data
- Incorporate management strategies for the adverse gastrointestinal effects of GLP-1 RAs to improve patient adherence
**This activity is accredited for CME/CE Credit.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:** https://www.naceonline.com/courses/glp-1-ra-a-powerful-tool-for-risk-reduction-in-diabetes
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0 hours of pharmacology).
This educational activity is supported by an independent educational grant from Novo Nordisk Inc.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit: https://www.naceonline.com/courses/treating-iron-deficiency-anemia-what-you-need-to-know-now
Featuring speakers Lee P. Shulman, MD, and Wendy L. Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP, moderated by Gregg Sherman, MD.
Summary
As prevalent as IDA is in the population, how do you treat their anemia and replete iron stores? Sulfate, gluconate, or maltol? This discussion, between two respective experts in primary care and OB/GYN and our primary care moderator, continues and concludes our 2-part podcast series to answer that question. Oral and parenteral iron repletion, managing and mitigating side effects, and monitoring efficacy of treatment round out the discussion on the management of IDA.
This podcast was recorded and is being used with the permission of the presenters.
Learning Objective
Upon completion of this activity, learners should be able to:
- Utilize an evidence-based, patient approach to management of iron deficiency that maximizes adherence to treatment
- Accurately assess iron stores in patients with anemia and those on iron replacement therapy.
**This activity is accredited for CME/CE Credit.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:** https://www.naceonline.com/courses/treating-iron-deficiency-anemia-what-you-need-to-know-now
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0 hours of pharmacology).
This activity is supported by an educational grant from Shield Therapeutics.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit: https://www.naceonline.com/courses/the-unmet-needs-of-iron-deficiency-screening-diagnosisFeaturing speakers Lee P. Shulman, MD, and Wendy L. Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP, moderated by Gregg Sherman, MD.
Summary
Do you consider iron deficiency anemia (IDA) as much as you should in at-risk patients? A third of the US population will experience IDA in their lifetime, whether due to blood loss or nutritional deficiency. How do you determine which third of your patients have or are at risk for this condition? In this, the first of a 2-podcast series on IDA, experts in primary care and OB/GYN discuss with our primary care moderator the identification of patients who need screening for anemia and iron deficiency and how to screen and diagnose those patients. Hemoglobin, transferrin saturation, serum iron, ferritin! With so many options, how does a provider thoughtfully approach the workup of IDA? Tune in, and find out.
This podcast was recorded and is being used with the permission of the presenters.
Learning Objective
Upon completion of this activity, learners should be able to:
- Recognize patients at risk for iron deficiency anemia
- Accurately assess iron stores in patients with anemia and those on iron replacement therapy
**This activity is accredited for CME/CE Credit.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:** https://www.naceonline.com/courses/the-unmet-needs-of-iron-deficiency-screening-diagnosis
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0 hours of pharmacology).
This activity is supported by an educational grant from Shield Therapeutics.
Podcast Series Title: The 411 on a GLP-1
Podcast Series Description: Join series host Dr. Jim Gavin, Clinical Professor of Medicine at Emory University and Chief Medical Officer for Healing our Village in Atlanta, Georgia, and fellow leaders in the field of diabetes as they tackle some of the challenges we face when treating T2D. Topics of discussion include clinical inertia, as well as the mechanism of action, dosing, efficacy, and safety of a GLP-1 RA for adults with T2D.
This podcast is sponsored by Novo Nordisk and is intended for clinicians.
Episode Title: Could This GLP-1 RA be Right for Your Adult Patients With T2D?
Episode Description: Join leaders in the field of diabetes Dr. Jim Gavin, Dr. Pablo Mora, and Dr. Bob Busch as they navigate through a clinical study. What do you need to know about using a GLP-1 RA for glycemic control with patients who have T2D? Are there any considerations for specific populations such as those who have moderate renal impairment?
This program is intended for clinicians. The information presented is aligned with the views and opinions of the speakers and is sponsored by Novo Nordisk. This podcast is not to be used as medical advice and is intended for educational purposes only.Faculty Presenters:
James R. Gavin III, MD, PhD
Clinical Professor of Medicine, Emory University
Chief Medical Officer, Healing Our Village, Inc.
Atlanta, Georgia
Robert Busch, MD
Director of Clinical Research
Albany Med Faculty Practice, Community Endocrine Group
Albany, New York
Pablo F. Mora, MD, FACE, MSc, CDCES
Endocrinologist, North Texas Diabetes & Endocrinology
Clinical Professor, Division of Endocrinology at University of Texas
Southwestern Medical Center
Dallas, Texas
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.naceonline.com/courses/managing-hfpef-incorporating-evolving-data-into-practice-3-an-evolving-algorithm
Featuring speaker Javed Butler, MD, MPH, MBA, moderated by Alanna Morris, MD, MSc, FHFSA, FACC, FAHA, and contributing faculty Biykem Bozkurt, MD, PhD, FHFSA, FACC, FAHA, FACP
Summary
Approximately 50% of patients with heart failure (HF) have preserved ejection fraction (HFpEF), and the prevalence of HFpEF relative to HF with reduced ejection fraction (HFrEF) has been increasing by about 1% per year. If this trend continues, HFpEF will become the most common type of HF in the near future. Early diagnosis and treatment of HFpEF are important to help prevent hospitalizations and complications, especially because new treatment options are available that improve outcomes for patients with HFpEF.
In this 3-part educational podcast series moderated by Dr. Alanna Morris, expert faculty discuss the management of HFpEF and incorporating evolving data into practice. In part 3, Dr. Javed Butler and Dr. Alanna Morris discuss best practices for integrating new and emerging therapies into the management of patients with HFpEF.
This podcast was recorded and is being used with the permission of the presenters.
Learning Objective
Upon completion of this activity, learners should be able to:
- Integrate current and emerging data into the management of patients with chronic HFpEF
**This activity is accredited for CME/CE Credit.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:**https://www.naceonline.com/courses/managing-hfpef-incorporating-evolving-data-into-practice-3-an-evolving-algorithm
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0.25 hours of pharmacology).
This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.naceonline.com/courses/managing-hfpef-incorporating-evolving-data-into-practice-1-heart-failure-new-definitions-and-classificationsFeaturing speaker Biykem Bozkurt, MD, PhD, FHFSA, FACC, FAHA, FACP, moderated by Alanna Morris, MD, MSc, FHFSA, FACC, FAHA, and contributing faculty Javed Butler, MD, MPH, MBA
Summary
Approximately 50% of patients with heart failure (HF) have preserved ejection fraction (HFpEF), and the prevalence of HFpEF relative to HF with reduced ejection fraction (HFrEF) has been increasing by about 1% per year. If this trend continues, HFpEF will become the most common type of HF in the near future. Early diagnosis and treatment of HFpEF are important to help prevent hospitalizations and complications, especially because new treatment options are available that improve outcomes for patients with HFpEF.
In this 3-part educational podcast series moderated by Dr. Alanna Morris, expert faculty discuss the management of HFpEF and incorporating evolving data into practice. In part 1, Dr. Biykem Bozkurt and Dr. Alanna Morris describe the updated universal definition of HF, which has implications for improving HF diagnosis, assessment, and management.
This podcast was recorded and is being used with the permission of the presenters.
Learning Objective
Upon completion of this activity, learners should be able to:
- Describe the updated universal definition of HF
**This activity is accredited for CME/CE Credit.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:**https://www.naceonline.com/courses/managing-hfpef-incorporating-evolving-data-into-practice-1-heart-failure-new-definitions-and-classifications
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0 hours of pharmacology).
This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.naceonline.com/courses/managing-hfpef-incorporating-evolving-data-into-practice-2-new-data-and-evolving-strategies
Featuring speaker Javed Butler, MD, MPH, MBA, moderated by Alanna Morris, MD, MSc, FHFSA, FACC, FAHA, and contributing faculty Biykem Bozkurt, MD, PhD, FHFSA, FACC, FAHA, FACP
Summary
Approximately 50% of patients with heart failure (HF) have preserved ejection fraction (HFpEF), and the prevalence of HFpEF relative to HF with reduced ejection fraction (HFrEF) has been increasing by about 1% per year. If this trend continues, HFpEF will become the most common type of HF in the near future. Early diagnosis and treatment of HFpEF are important to help prevent hospitalizations and complications, especially because new treatment options are available that improve outcomes for patients with HFpEF.
In this 3-part educational podcast series moderated by Dr. Alanna Morris, expert faculty discuss the management of HFpEF and incorporating evolving data into practice. In part 2, Dr. Javed Butler and Dr. Alanna Morris discuss the latest data regarding new and emerging therapies for the treatment of HFpEF.
This podcast was recorded and is being used with the permission of the presenters.
Learning Objective
Upon completion of this activity, learners should be able to:
- Discuss evolving data for managing patients with chronic HFpEF
**This activity is accredited for CME/CE Credit.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:**https://www.naceonline.com/courses/managing-hfpef-incorporating-evolving-data-into-practice-2-new-data-and-evolving-strategies
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0 hours of pharmacology).
This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company.
Podcast Series Title: T2D: Don’t Sugar Coat It
Podcast Series Description: What are the main drivers of type 2 diabetes (T2D) and why does the diabetes epidemic continue to grow despite a wealth of information? Join series host Dr. John Anderson, past president of ADA, who practices internal medicine at the Frist Clinic, as he interviews fellow experts on the main drivers of T2D and how clinicians can optimize patient outcomes in this changing disease area.
Episode Title: The Role of Endogenous GLP-1 Episode Description: What is the role of endogenous GLP-1 in the pathophysiology of T2D? Join multidisciplinary experts in T2D: Dr. John Anderson, Dr. Vivian Fonseca, and Dr. Jim Gavin as they discuss the fascinating history of GLP-1 discovery and the role of endogenous GLP-1 in the pathophysiology of T2D.
This podcast is sponsored by Novo Nordisk and is intended for Healthcare Practitioners.Faculty Presenters:
John E. Anderson, MD
Internal Medicine and Diabetes
The Frist Clinic
Nashville, Tennessee
James R. Gavin III, MD, PhD
Clinical Professor of Medicine, Emory University
Chief Medical Officer, Healing Our Village, Inc.
Atlanta, Georgia
Vivian A. Fonseca, MD, FRCP
Professor of Medicine, Assistant Dean for Research
Tulane University
New Orleans, Louisiana
In Part three of the Second Anniversary Special, Dr. Skolnik interviews special guests, Chief Resident Dr Morgan Katz, and Resident Dr. Victoria Persampiere. Dr Katz and Dr. Persampiere, who share their experience of serving their entire medical residency during the pandemic, and answer audience questions.
Dr Wen, Dr. Skolnik, the producers, and the entire NACE team offer special thanks to the COVIDD-19 Update audience of over 100,000 health care workers and pandemic veterans who have attended these live virtual broadcasts and downloaded these podcast episodes . In Dr Skolnik's words "You are who makes these updates come alive!"
To view the full video episode (parts 1-3) of this podcast please visit https://vimeo.com/688026452/86459c5b78
Faculty
Co-Course Director and Moderator
Neil Skolnik, MD
Professor of Family and Community Medicine
Sidney Kimmel Medical College
Thomas Jefferson University
Associate Director
Family Medicine Residency Program
Abington Jefferson Health
Philadelphia, PA
Co-Course Director and Moderator
Leana S. Wen, MD, MSc
Professor, Health Policy and Management
Distinguished Fellow, Fitzhugh Mullan Institute for Health Workforce Equity
George Washington University School of Public Health
Washington, DC
Guest Faculty
Morgan Katz, DO
Chief Resident, Family Medicine
Abington-Jefferson Health
Abington, PA
Guest Faculty
Victoria Persampiere, DO
Abington Family Medicine, PGY-2
Abington, PA
______
Executive Producer
Stephen R. Webber
Produced by:
Stephen R. Webber
Sandy Bihlmeyer
Jason Jimmerson
Eleanor Franke
Directed By:
Stephen R. Webber
Created by:
Stephen R. Webber and Neil Skolnik, MD
This podcast was recorded on March 12, 2022.
This podcast is not accredited for CME credit.
In part two of this second anniversary special episode, Dr. Neil Skolnik and Dr. Leana Wen provide the up to the minute State of the Pandemic report.
Special thanks to our audience of dedicated clinician learners from Dr Wen, Dr. Skolnik, the producers, and the entire NACE team. In Dr Skolnik's words "You are what makes The NACE COVID-19 Update Come Alive!"
To watch the entire second Anniversary Special Episode please visit https://vimeo.com/688026452
Faculty
Co-Course Director and Moderator
Neil Skolnik, MD
Professor of Family and Community Medicine
Sidney Kimmel Medical College
Thomas Jefferson University
Associate Director
Family Medicine Residency Program
Abington Jefferson Health
Philadelphia, PA
Co-Course Director and Moderator
Leana S. Wen, MD, MSc
Professor, Health Policy and Management
Distinguished Fellow, Fitzhugh Mullan Institute for Health Workforce Equity
George Washington University School of Public Health
Washington, DC
Executive Producer
Stephen R. Webber
Produced by:
Stephen R. Webber
Sandy Bihlmeyer
Jason Jimmerson
Eleanor Franke
Directed By:
Stephen R. Webber
Created by:
Stephen R. Webber and Neil Skolnik, MD
This podcast was recorded on March 12, 2022.
This podcast is not accredited for CME credit.
Reflections, part one of the second anniversary special episode, begins with a retrospective compiled by the producers of the past 52 episodes to provide us all with a moment to think about the path we have endured together over the past two years of the COVID-19 pandemic. Following the retrospective, Dr. Leana Wen and Dr. Neil Skolnik reflect on their experience providing 52 evidence-based updates and answering attendee questions since Episode 1 on March 14, 2020.
Dr Wen, Dr. Skolnik, the producers, and the entire NACE team offer special thanks to the COVIDD-19 Update audience of over 100,000 health care workers and pandemic veterans who have attended these live virtual broadcasts and downloaded these podcast episodes . In Dr Skolnik's words "You are who makes these updates come alive!"
To view the full video episode (parts 1-3) of this podcast please visit https://vimeo.com/688026452/86459c5b78
This podcast was recorded on March 12, 2022.
This podcast is not accredited for CME credit.
Faculty
Co-Course Director and Moderator
Neil Skolnik, MD
Professor of Family and Community Medicine
Sidney Kimmel Medical College
Thomas Jefferson University
Associate Director
Family Medicine Residency Program
Abington Jefferson Health
Philadelphia, PA
Co-Course Director and Moderator
Leana S. Wen, MD, MSc
Professor, Health Policy and Management
Distinguished Fellow, Fitzhugh Mullan Institute for Health Workforce Equity
George Washington University School of Public Health
Washington, DC
Special Guests in order of appearance:
Reverend Dr. Robert L. Brashear
Susan Fidler, MD
Morgan Katz, DO
Wendy L. Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP
Executive Producer
Stephen R. Webber
Produced by:
Stephen R. Webber
Sandy Bihlmeyer
Jason Jimmerson
Eleanor Franke
Directed By:
Stephen R. Webber
Created by:
Stephen R. Webber and Neil Skolnik, MD
This Podcast Was recorded on March 12, 2020
This podcast is not available for CME Credit
In this episode, Dr. Leana Wen and Dr. Neil Skolnik discuss the up to the minute state of the COVID-19 pandemic, provide updates regarding vaccine boosters, outpatient therapy options, and guidelines for healthcare workers, and answer attendee questions.
This podcast was recorded on January 25, 2022.
This podcast is not accredited for CME credit.
In this episode, Dr. Leana Wen and Dr. Neil Skolnik discuss the up to the minute state of the COVID-19 pandemic, provide an update regarding vaccine boosters, and discuss management of outpatient COVID-19.
This segment was recorded on December 11, 2021 at the NACE Emerging Challenges and Clinical Updates in Primary Care 2021 Live Virtual Conference.
This webcast is not accredited for CME credit.
Summary
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:Risk Assessment in Pulmonary Arterial Hypertension and Right Heart Failure: Individualizing Therapy Podcast
In this podcast episode, Dr. Raymond L. Benza and Dr. Alanna Morris will discuss early diagnosis, effective monitoring, and new treatment approaches to ensure timely treatment and to optimize the management of patients with PAH and RHF.
Pulmonary arterial hypertension (PAH) is a progressive and life-threatening condition for which early diagnosis and treatment are crucial. However, early recognition of PAH can be challenging because the disease does not become clinically manifest until pulmonary vascular disease is advanced. Right heart failure (RHF) is the most common cause of death in PAH patients, and newer treatments are available that can reduce right ventricular afterload, improve exercise capacity, and improve quality of life. In addition, clinicians may not have an algorithm for PAH management and may be unclear about PAH treatment goals, management strategies, and monitoring for disease activity.
This podcast was recorded and is being used with the permission of the presenters.
Learning Objectives
Upon completion of this activity, learners should be able to:
- Utilize updated definitions and diagnostic evaluations to recognize patients with PAH.
- Incorporate evidence for new and emerging treatments into the management of patients with PAH and RHF.
This activity is accredited for CME/CE credit.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:Risk Assessment in Pulmonary Arterial Hypertension and Right Heart Failure: Individualizing Therapy Podcast
Speaker
Raymond L. Benza, MD, FACC, FAHA, FCCP
Professor of Medicine
Bob and Corrine Frick Chair of Heart Failure
Division of Cardiovascular Medicine
The Ohio State University
Columbus, OH
Moderator/Course Director
Alanna Morris, MD, MSc, FHFSA, FACC, FAHA
Associate Professor of Medicine, Division of Cardiology
Director of Heart Failure Research
Emory University Clinical Cardiovascular Research Institute
Emory University School of Medicine
Atlanta, GA
Planning Committee
Sandy Bihlmeyer, MEd
Senior Project Manager
National Association for Continuing Education
Plantation, FL
Michelle Frisch, MPH
Vice President, Operations
National Association for Continuing Education
Plantation, FL
Angela Golden, DNP, FNP-C, FAANP
Family Nurse Practitioner
NP Obesity Treatment Clinic and NP from Home, LLC
Assistant Professor (Ret), Northern Arizona University
Past President, American Association of Nurse Practitioners
Munds Park, AZ
Daniela Hiedra
Activity Director
National Association for Continuing Education
Plantation, FL
Joshua F. Kilbridge
President and Creative Director
Kilbridge Associates
San Francisco, CA
Gregg Sherman, MD
Chief Medical Officer
Course Director
National Association for Continuing Education
Plantation, FL Provided By
National Association for Continuing Education
NACE Accreditation Statement
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide c
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:Considering a Non-Steroidal MRA for CKD...Here's What You Need to Know! Part 3 -Managing CKD: The Role of Non-Steroidal MRAsFeaturing Katherine R. Tuttle, MD, FASN, FACP, FNKF as faculty, moderated by Robert D. Toto, MD.
Summary
In this 3-part educational podcast series moderated by Dr. Robert D. Toto, faculty discuss the management of chronic kidney disease using a non-steroidal MRA and what you really need to know now. In part 3, Dr. Katherine Tuttle and Dr. Robert D. Toto discuss exciting new developments in the management of patients with diabetic kidney disease.
Chronic kidney disease (CKD) is associated with increased cardiovascular risk, and mortality in CKD patients is often due to cardiovascular disease (CVD). Inflammation, fibrosis, and the mineralocorticoid receptor (MR) play important roles in CKD progression and CVD risk, while MR antagonists (MRAs) reduce CVD risk and CKD progression. Older steroidal MRAs have several limitations, including causing hyperkalemia, which is a potentially serious electrolyte abnormality that is already more common among CKD patients. This podcast series will provide clinicians with additional information on available MRAs and how to use them in the care of patients with CKD.
This podcast was recorded and is being used with the permission of the presenters.
Learning Objectives
Upon completion of this activity, learners should be able to:
- Identify patients who are appropriate candidates for non-steroidal MRAs in the management of CKD
**This activity is accredited for CME/CE credit.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:**Considering a Non-Steroidal MRA for CKD...Here's What You Need to Know! Part 3 -Managing CKD: The Role of Non-Steroidal MRAsThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0 hours of pharmacology).
This activity is supported by an educational grant from Bayer HealthCare Pharmaceuticals Inc.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:Considering a Non-Steroidal MRA for CKD...Here's What You Need to Know! Part 2 -CKD and Cardiovascular Risk - The Evolving Connection
Featuring George Bakris, MD as faculty, moderated by Robert D. Toto, MD.
Summary
In this 3-part educational podcast series moderated by Dr. Robert D. Toto, faculty discuss the management of chronic kidney disease using a non-steroidal MRA and what you really need to know now. In part 2, Dr. George Bakris and Dr. Robert D. Toto discuss the roles of inflammation, fibrosis, and the mineralocorticoid receptor in the progression of chronic kidney disease.
Chronic kidney disease (CKD) is associated with increased cardiovascular risk, and mortality in CKD patients is often due to cardiovascular disease (CVD). Inflammation, fibrosis, and the mineralocorticoid receptor (MR) play important roles in CKD progression and CVD risk, while MR antagonists (MRAs) reduce CVD risk and CKD progression. Older steroidal MRAs have several limitations, including causing hyperkalemia, which is a potentially serious electrolyte abnormality that is already more common among CKD patients. This podcast series will provide clinicians with additional information on available MRAs and how to use them in the care of patients with CKD.
This podcast was recorded and is being used with the permission of the presenters.
Learning Objectives
Upon completion of this activity, learners should be able to:
- Recognize how inflammation, fibrosis, and the MR play a role in the progression of CKD, including their impact on cardiovascular risk
**This activity is accredited for CME/CE credit.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:**Considering a Non-Steroidal MRA for CKD...Here's What You Need to Know! Part 2 -CKD and Cardiovascular Risk - The Evolving Connection
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0 hours of pharmacology).
This activity is supported by an educational grant from Bayer HealthCare Pharmaceuticals Inc.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:Considering a Non-Steroidal MRA for CKD...Here's What You Need to Know! Part 1 - Recognizing and Reducing Hyperkalemia Risk in CKD Patients
Featuring George Bakris, MD as faculty, moderated by Robert D. Toto, MD.
Summary
In this 3-part educational podcast series moderated by Dr. Robert D. Toto, faculty discuss the management of chronic kidney disease using a non-steroidal MRA and what you really need to know now. In part 1, Dr. George Bakris and Dr. Robert D. Toto discuss the clinical risks of hyperkalemia in chronic kidney disease and ways to reduce these risks.
Chronic kidney disease (CKD) is associated with increased cardiovascular risk, and mortality in CKD patients is often due to cardiovascular disease (CVD). Inflammation, fibrosis, and the mineralocorticoid receptor (MR) play important roles in CKD progression and CVD risk, while MR antagonists (MRAs) reduce CVD risk and CKD progression. Older steroidal MRAs have several limitations, including causing hyperkalemia, which is a potentially serious electrolyte abnormality that is already more common among CKD patients. This podcast series will provide clinicians with additional information on available MRAs and how to use them in the care of patients with CKD.
This podcast was recorded and is being used with the permission of the presenters.
Learning Objectives
Upon completion of this activity, learners should be able to:
- Identify strategies to reduce the risk of hyperkalemia in patients with CKD
**This activity is accredited for CME/CE Credit.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:**Considering a Non-Steroidal MRA for CKD...Here's What You Need to Know! Part 1 - Recognizing and Reducing Hyperkalemia Risk in CKD Patients
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0 hours of pharmacology).
This activity is supported by an educational grant from Bayer HealthCare Pharmaceuticals Inc.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:Optimizing Asthma Outcomes: Difficult-to-Treat and Severe Asthma in Primary Care Podcast
Featuring Neil Skolnik, MD as faculty, moderated by Gregg Sherman, MD.
Summary
In this episode, Dr. Skolnick and Dr. Sherman address recent advances in asthma treatment which allow for greater individualization of therapy, particularly for patients with difficult-to-treat and severe asthma. Available therapies are highly effective for asthma management, yet for a number of reasons, in practice, asthma is often not optimally controlled. This podcast will help clinicians recognize how to identify asthma phenotypes to guide therapeutic decision making, incorporate the most recent GINA guidelines into practice, and identify patients with moderate to severe asthma that require more aggressive care, including biologic therapy.
This podcast was recorded and is being used with the permission of the presenters.
Learning Objectives
Upon completion of this activity, learners should be able to:
- Recognize different phenotypes, asthma severity, and modifiable and non-modifiable factors that contribute to poor asthma control in order to make personalized treatment decisions
- Select guideline-directed therapy and patient management strategies, including referral when appropriate, based on individualized characteristics in patients with difficult-to-treat or severe asthma
**This activity is accredited for CME/CE credit.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:**Optimizing Asthma Outcomes: Difficult-to-Treat and Severe Asthma in Primary Care Podcast
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0 hours of pharmacology).
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc and Sanofi Genzyme.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:Advances in HFrEF: Slowing a Poor Hospital Prognosis, Part 1- Stratifying Risk Podcast
Featuring James L. Januzzi Jr., MD, FACC, FESC as faculty, moderated by Alanna Morris, MD, MSc, FHFSA, FACC, FAHA.
Summary
In this 2-part educational podcast series, Dr. James Januzzi and Dr. Alanna Morris discuss new therapies and treatment strategies for management of patients with HF and reduced ejection fraction (HFrEF). In part 1, the faculty review aspects of risk stratification in patients with HFrEF and why stratifying risk for these patients is so important.
Heart failure (HF) accounts for around one million hospitalizations in the United States every year, and approximately 50% of these are caused by HF with reduced ejection fraction (HFrEF). Optimal care for patients with HFrEF continues to be refined with the recent advancements in drug and device therapies that can reduce the incidence of cardiovascular (CV) death or hospitalization and improve the prognosis of patients with HFrEF. Clinicians need updated information regarding these recent advancements, when and how to use them, and recommendations for adhering to guideline-directed medical therapies (GDMT) for HF.
This podcast was recorded and is being used with the permission of the presenters.
Learning Objective
Upon completion of this activity, learners should be able to:
- Identify disease and patient characteristics that increase the risk of re-hospitalization or CV death in people with heart failure
**This activity is accredited for CME/CE credit.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:**Advances in HFrEF: Slowing a Poor Hospital Prognosis, Part 1- Stratifying Risk Podcast
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0 hours of pharmacology).
This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:Migraine Management: Are You Up To Speed? Podcast
Featuring Alan M. Rapoport, MD as faculty, moderated by Gregg Sherman, MD.
Summary
Recent advances in the understanding and treatment of migraine offer the opportunity to individualize the care of patients with this disorder. Multiple new treatment options are available, marking a new era in migraine management. As older therapies for migraine are associated with adverse effects that may be intolerable, PCPs need to be familiar with clinical trial data for newer drug therapies that are both effective and well tolerated, in order to be able to make appropriate management decisions. This course will review the use of acute care therapies to manage migraine, based on therapies’ mechanisms of action, safety, and efficacy data, as well as the patient’s preferences; and preventive therapy to manage patients with migraine, based on therapies’ mechanisms of action, clinical trial data, and side-effect profile, as well as the patient’s preferences.
This podcast was recorded and is being used with the permission of the presenters.
Learning Objectives
Upon completion of this activity, learners should be able to:
- Individualize the use of acute care therapies to manage migraine, based on therapies’ mechanisms of action, safety, and efficacy data, as well as the patient’s preferences.
- Utilize preventive therapy to manage patients with migraine, based on therapies’ mechanisms of action, clinical trial data, and side-effect profile, as well as the patient’s preferences.
**This activity is accredited for CME/CE credit.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:**Migraine Management: Are You Up To Speed? Podcast
Accreditation Statement– CME ProviderIn support of improving patient care, Albert Einstein College of Medicine-Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statement
Albert Einstein College of Medicine-Montefiore Medical Center designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credit for learning and change.
Accreditation Statement – AANP ProviderNational Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0.25 hours of pharmacology).
This activity is supported by an educational grant from Biohaven Pharmaceuticals.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:Advances in HFrEF: Slowing a Poor Hospital Prognosis, Part 2 - Evidence-Based Management Podcast
Featuring James L. Januzzi Jr., MD, FACC, FESC as faculty, moderated by Alanna Morris, MD, MSc, FHFSA, FACC, FAHA.
Summary
In this 2-part educational podcast series, Dr. James Januzzi and Dr. Alanna Morris discuss new therapies and treatment strategies for management of patients with heart failure and reduced ejection fraction (HFrEF). In part 2, the faculty review new developments in the management of and guideline-directed medical therapy for patients with HFrEF.
Heart failure (HF) accounts for around one million hospitalizations in the United States every year, and approximately 50% of these are caused by HF with reduced ejection fraction (HFrEF). Optimal care for patients with HFrEF continues to be refined with the recent advancements in drug and device therapies that can reduce the incidence of cardiovascular (CV) death or hospitalization and improve the prognosis of patients with HFrEF. Clinicians need updated information regarding these recent advancements, when and how to use them, and recommendations for adhering to guideline-directed medical therapies (GDMT) for HF.
This podcast was recorded and is being used with the permission of the presenters.
Learning Objectives
Upon completion of this activity, learners should be able to:
- Apply evidence-based GDMT when treating patients with chronic heart failure, including up-titration of medications to meet recommended target levels
- Identify patient populations with symptomatic, chronic HFrEF who would benefit from newer agents, based on safety and efficacy data and individual patient characteristics
**This activity is accredited for CME/CE credit.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:**Advances in HFrEF: Slowing a Poor Hospital Prognosis, Part 2 - Evidence-Based Management Podcast
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0.25 hours of pharmacology).
This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company.
Dr. Leana Wen and Dr. Neil Skolnik discuss the up to the minute state of the COVID-19 pandemic, including the latest evidence about COVID-19 Vaccine related myocarditis cases, an update on Delta and other variants, and Dr. Wen and Dr. Skolnik reflect on their experience professionally and personally during the pandemic and their experience providing these updates at over 25 NACE live virtual CME/CE conferences since it's premiere on March 14, 2020, 2 days before the first shutdown occurred.
This segment was recorded on June 26, 2021, at the NACE Emerging Challenges and Clinical Updates in Primary Care 2021 Live Virtual Conference, episode 8.
FacultyLeana S. Wen, MD, MScVisiting Professor, Health Policy and ManagementDistinguished Fellow, Fitzhugh Mullan Institute for Health Workforce EquityGeorge Washington University School of Public HealthWashington, DC
Neil Skolnik, MDProfessor of Family and Community MedicineSidney Kimmel Medical CollegeThomas Jefferson UniversityPhiladelphia, PA
This podcast is not accredited for CME credit.
Dr. Leana Wen and Dr. Neil Skolnik discuss the up to the minute state of the COVID-19 pandemic, including the latest information on the Delta and other variants currently circulating in the U.S., the importance of vaccinations in the mitigation of the risk of infection by variants, and answer audience questions on topics currently impacting primary care practice. This segment was recorded on June 19, 2021, at the NACE Emerging Challenges and Clinical Updates in Primary Care 2021 Live Virtual Conference, episode 7.
Faculty
Leana S. Wen, MD, MSc
Visiting Professor, Health Policy and Management
Distinguished Fellow, Fitzhugh Mullan Institute for Health Workforce Equity
George Washington University School of Public Health
Washington, DC
Neil Skolnik, MD
Professor of Family and Community Medicine
Sidney Kimmel Medical College
Thomas Jefferson University
Philadelphia, PA
This podcast is not accredited for CME credit.
Dr. Leana Wen and Dr. Neil Skolnik discuss the up to the minute state of the COVID-19 pandemic, including the latest information on the progress on vaccinations for children, the COVID-19 variants currently of concern, answer audience questions on topics that impact clinical practice each day.
This segment was recorded on June 12, 2021, at the NACE Emerging Challenges and Clinical Updates in Primary Care 2021 Live Virtual Conference, episode 6.
Faculty
Leana S. Wen, MD, MSc
Visiting Professor, Health Policy and Management
Distinguished Fellow, Fitzhugh Mullan Institute for Health Workforce Equity
George Washington University School of Public Health
Washington, DC
Neil Skolnik, MD
Professor of Family and Community Medicine
Sidney Kimmel Medical College
Thomas Jefferson University
Philadelphia, PA
This podcast episode is not accredited for CME credit.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:Effective Management of Pulmonary Arterial Hypertension: Primary Care’s Primary Role Podcast
Featuring Stacy A. Mandras, MD, FACC as faculty, moderated by Gregg Sherman, MD.
Pulmonary arterial hypertension (PAH) is a progressive and life-threatening condition characterized by increased pulmonary vascular resistance which can lead to right heart failure and premature death. As first-line healthcare providers, primary care clinicians play a key role in the early recognition of PAH, and referral of patients to specialists to confirm the diagnosis. Thereafter, primary care providers (PCPs) also play a crucial role in the ongoing monitoring and management of PAH patients. However, in practice, early recognition and management of PAH is challenging as PAH does not become clinically manifest until pulmonary vascular disease is advanced. This activity will focus on PAH diagnostic tools, monitoring, and management strategies to optimize care and patient outcomes.
This podcast was recorded and is being used with the permission of the presenters.
Learning Objectives
Upon completion of this activity, learners should be able to:
- Diagnose PAH using updated definitions and diagnostic tools
- Promote patient adherence through the management of adverse events that are associated with PAH therapies
**This activity is accredited for CME/CE credit.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:**Effective Management of Pulmonary Arterial Hypertension: Primary Care’s Primary Role Podcast
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0 hours of pharmacology).
This educational activity is supported by an educational grant from Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson.
Dr. Leana Wen and Dr. Neil Skolnik discuss the up to the minute state of the COVID-19 pandemic, including the new CDC guidelines for no masks and social distancing for vaccinated people, the current vaccination status of the U.S. population, and answer audience questions on topics that impact clinical practice each day.
This segment was recorded on May 15, 2021 at the NACE Conversations in Primary Care 2021, episode 4, Live Virtual Conference.
Faculty
Leana S. Wen, MD, MSc
Visiting Professor, Health Policy and Management
Distinguished Fellow, Fitzhugh Mullan Institute for Health Workforce Equity
George Washington University School of Public Health
Washington, DC
Neil Skolnik, MD
Professor of Family and Community Medicine
Sidney Kimmel Medical College
Thomas Jefferson University
Philadelphia, PA
This podcast episode is not accredited for CME credit.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:A Guideline Approach to Managing Diabetes: Improving Outcomes with GLP-1 RA Therapy PodcastFeaturing James R. Gavin III, MD, PhD as faculty, moderated by Gregg Sherman, MD.
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a relatively newer drug group for type 2 diabetes (T2DM) management, which demonstrate excellent efficacy for glycemic control. They reduce HbA1c and have low glycemic variability and a low risk of hypoglycemia. GLP-1 RAs also delay gastric emptying, reduce appetite, and promote weight loss. Subsequently, GLP-1 RAs are the preferred agents to treat T2DM patients in whom there is a compelling need to minimize hypoglycemia or to minimize weight gain/promote weight loss. Initiating therapy with a GLP-1 RA ahead of insulin may be preferred for patients who need an injectable’s greater glucose-lowering effect. Recent cardiovascular outcome trials (CVOTs) have also demonstrated the cardiorenal benefits of some GLP-1 RAs, and these agents are indicated for T2DM patients who have atherosclerotic cardiovascular disease (ASCVD) or indicators of high risk, established kidney disease or heart failure. This course will address diagnosis, treatment, and clinician-patient communication strategies to optimize patient care.
This podcast was recorded and is being used with the permission of the presenters.
Learning Objectives
Upon completion of this activity, learners should be able to:
- Describe the glycemic and non-glycemic benefits of various GLP-1 receptor agonists that are currently available as well as the patient profile for which GLP-1 receptor agonists produced the best outcomes
- Optimize treatment selection of GLP-1 receptor agonist therapy for patients with type 2 diabetes (T2D) based on current guidelines, patient characteristics, and evolving outcome data
- Utilize effective communication to optimize shared decision-making and involve patients in discussions concerning GLP-1 receptor agonist therapy in order to decrease barriers to care, improving adherence, decrease cardiovascular risk, and optimize patient outcomes
**This activity is accredited for CME/CE credit.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:**A Guideline Approach to Managing Diabetes: Improving Outcomes with GLP-1 RA Therapy Podcast
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0 hours of pharmacology).
This educational activity is supported by an educational grant from Novo Nordisk, Inc.
Dr. Leana Wen is joined by Dr. Chris Notte for this episode. Dr. Wen presents the top vaccine questions, concerns, and viewpoints that she and many clinicians are getting from patients, and provides insight and answers that you can implement into your practice immediately. Dr. Chris Notte provides an update on COVID-19 testing and the impact vaccine uptake and availability is having on guidelines and health system policies.
Faculty
Leana S. Wen, MD, MSc
Visiting Professor, Health Policy and Management
Distinguished Fellow, Fitzhugh Mullan Institute for Health Workforce Equity
George Washington University School of Public Health
Washington, DC
Christopher Notte, MD
Chief Medical Officer
Abington-Lansdale Hospital
Asst. Chief Medical Information Officer
Jefferson Health
Clinical Asst. Professor, Dept. of Family &
Community Medicine
Thomas Jefferson University
Abington, PA
This Podcast is not accredited for CME credit.
Dr. Leana Wen and Dr. Neil Skolnik discuss the up to the minute state of the COVID-19 pandemic, the current vaccination status of the U.S. population, update on status of the J&J vaccine and concerns around blood clots, and a discussion about vaccine hesitancy.
This segment was recorded on May 1, 2021 at the NACE Emerging Challenges and Clinical Updates in Primary Care 2021 Live Virtual Conference.
Faculty
Leana S. Wen, MD, MSc
Visiting Professor, Health Policy and Management
Distinguished Fellow, Fitzhugh Mullan Institute for Health Workforce Equity
George Washington University School of Public Health
Washington, DC
Neil Skolnik, MD
Professor of Family and Community Medicine
Sidney Kimmel Medical College
Thomas Jefferson University
Philadelphia, PA
This podcast is not accredited for CME credit.
Dr. Leana Wen and Dr. Neil Skolnik discuss the up to the minute state of the COVID-19 pandemic, including the possibility of a fourth surge, the current vaccination status of the U.S. population, new CDC guidelines for fully vaccinated individuals, and an update on the pathophysiology, clinical manifestations, and clinical evaluation and treatment of COVID-19 Long Haulers Syndrome (Post Acute Sequelae of Covid-19).
This segment was recorded on April 10, 2021 at the NACE Conversations in Primary Care 2021 live virtual broadcast, Episode 3.
Faculty
Leana S. Wen, MD, MSc
Visiting Professor, Health Policy and Management
Distinguished Fellow, Fitzhugh Mullan Institute for Health Workforce Equity
George Washington University School of Public Health
Washington, DC
Neil Skolnik, MD
Professor of Family and Community Medicine
Sidney Kimmel Medical College
Thomas Jefferson University
Philadelphia, PA
This podcast is not accredited for CME credit.
Dr. Fernando Martinez, Chief of the Division of Pulmonary and Critical Care Medicine Weill Cornell Medical College in New York, NY joins Dr. Leana Wen and Dr. Neil Skolnik to discuss the up to the minute state of the COVID-19 pandemic and an update on the pathophysiology, clinical manifestations, and clinical evaluation and treatment of COVID-19 Long Haulers Syndrome (Post Acute Sequelae of Covid-19).
This segment was recorded on April 17, 2021 at the NACE Conversations in Pulmonology 2021 live virtual broadcast.
Faculty
Leana S. Wen, MD, MSc
Visiting Professor, Health Policy and Management
Distinguished Fellow, Fitzhugh Mullan Institute for Health Workforce Equity
George Washington University School of Public Health
Washington, DC
Neil Skolnik, MD
Professor of Family and Community Medicine
Sidney Kimmel Medical College
Thomas Jefferson University
Philadelphia, PA
Fernando J. Martinez, MD, MS
Chief, Division of Pulmonary and Critical Care Medicine
Bruce Webster Professor of Medicine
Joan and Sanford I. Weill Department of Medicine
Weill Cornell Medical College
New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY
This podcast is not accredited for CME credit.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:Are You Providing The Most Up To Date Care in Moderate-to-Severe Atopic Dermatitis?
Featuring Anna Yasmine Kirkorian, MD as faculty, moderated by Brad P. Glick, DO, MPH, FAAD.
Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by pruritus and spongiotic dermatitis that severely impacts quality of life (QoL) and places a heavy burden on patients and families. Many patients, particularly those with moderate-to-severe AD, are inadequately managed by conventional therapies and may require treatment with newer targeted agents to achieve treatment success. New and emerging therapies are revolutionizing the management of AD and are changing the treatment paradigm by offering a personalized approach to management. Dermatologists and allergists play key roles in guiding the selection and use of newer therapies in appropriate patients and will benefit from increased familiarity with new treatments and evidence-based guidelines.
This podcast was recorded and is being used with the permission of the presenters.
Learning Objectives
Upon completion of this activity, learners should be able to:
- Recognize the burden of moderate-to-severe atopic dermatitis (AD), and the importance of patient and caregiver education for optimal management.
- Implement individualized treatment strategies for patients with moderate-to-severe AD, based on guideline recommendations, data on new and emerging treatments, management of comorbidities, and optimization of quality of life.
**This activity is accredited for CME/CE credit.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:**Are You Providing The Most Up To Date Care in Moderate-to-Severe Atopic Dermatitis?
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hour (which includes 0 hours of pharmacology).
This educational activity is supported by an educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals.
For more info on this topic, join NACE on June 5, 2021 for our live Conversations in Dermatology virtual program with Drs. Brad Glick, Yasmine Kirkorian and Adam Friedman.
Dr. Leana Wen and Dr. Neil Skolnik discuss the up to the minute state of the COVID-19 pandemic, including the possibility of a fourth surge, the current vaccination status of the U.S. population, new CDC guidelines for fully vaccinated individuals, and an update on the pathophysiology, clinical manifestations, and clinical evaluation and treatment of COVID-19 Long Haulers Syndrome (Post Acute Sequelae of Covid-19).
This segment was recorded on April 10, 2021 at the NACE Conversations in Primary Care 2021 live virtual broadcast, Episode 3.
Faculty
Leana S. Wen, MD, MSc
Visiting Professor, Health Policy and Management
Distinguished Fellow, Fitzhugh Mullan Institute for Health Workforce Equity
George Washington University School of Public Health
Washington, DC
Neil Skolnik, MD
Professor of Family and Community Medicine
Sidney Kimmel Medical College
Thomas Jefferson University
Philadelphia, PA
This webcast is not accredited for CME credit.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:
https://www.naceonline.com/courses/using-natriuretic-peptides-effectively-in-heart-failure-podcast?client=
Featuring James L. Januzzi, MD, FACC, FESC as faculty, moderated by Gregg Sherman, MD.
This course will review natriuretic peptide (NP) testing, based on guideline recommendations, to diagnose heart failure (HF), including patients in high-risk populations, such as those with diabetes mellitus or hypertension. In addition, the course will cover NP testing for prognostication in patients with established HF, or at risk for HF, including those with existing comorbidities such as diabetes mellitus or hypertension, as part of their overall disease monitoring and pharmacotherapeutic management.
Originally limited to the diagnosis of acute heart failure (HF) in the emergency room, natriuretic peptides (NPs) are now considered valuable markers that can be useful in the screening, diagnosis, prognostication, and monitoring of patients with HF. NP testing can be used to rule out HF in patients presenting with acute or chronic dyspnea, for prognostication in patients diagnosed with HF, and to guide therapy for chronic HF patients. As primary care clinicians play a crucial role in the early recognition and ongoing monitoring of patients with HF, it is important that they be familiar with the role of NPs in HF and with current recommendations regarding NP testing for screening, diagnosis, prognostication, and monitoring in HF in order to improve patient care and outcomes.
**This activity is accredited for CME/CE credit.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:**
https://www.naceonline.com/courses/using-natriuretic-peptides-effectively-in-heart-failure-podcast?client=
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.5 contact hour (which includes 0 hours of pharmacology).
This educational activity is supported by an educational grant from Roche Diagnostics Corporation.
Dr. Leana Wen and Dr. Neil Skolnik discuss the current state of the COVID-19 pandemic, concerns surrounding new variants, clinical considerations for vaccines, and the state and challenges of the vaccine rollout in the U.S.
This segment was recorded on February 13, 2021, at the NACE Conversations in Primary Care 2021, episode 1, broadcast.
Faculty
Leana S. Wen, MD, MSc
Visiting Professor, Health Policy and Management
Distinguished Fellow, Fitzhugh Mullan Institute for Health Workforce Equity
George Washington University School of Public Health
Washington, DC
Neil Skolnik, MD
Professor of Family and Community Medicine
Sidney Kimmel Medical College
Thomas Jefferson University
Philadelphia, PA
This webcast is not accredited for CME credit.
In this podcast, Dr. Adam Friedman and Dr. Gregg Sherman provide an update on appropriately diagnosing psoriasis, recognizing comorbidities, implementing appropriate therapeutic strategies, and the impact of COVID-19 with regards to treatment.
For CME programs on a variety of topics, visit the NACE website at https://www.naceonline.com/
Faculty
Adam Friedman, MD, FAAD
Professor and Interim Chair of Dermatology
Residency Program Director
Director of Translational Research
Director of Supportive Oncodermatology
Department of Dermatology
George Washington School of Medicine and Health Sciences
Washington, DC
This podcast was developed by Albert Einstein College of Medicine-Montefiore Medical Center in collaboration with NACE.
This educational activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.
This activity is not certified for CME/CE credit.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:
https://www.naceonline.com/courses/managing-heart-failure-in-primary-care-podcast
Featuring Alanna Morris, MD, MSc, FHFSA, FACC, FAHA as faculty, moderated by Gregg Sherman, MD.
This course will review evidence-based guidelines for early recognition and diagnosis of Heart Failure (HF), development of patient care plans that consider the latest guidelines and clinical data, as well as patient characteristics, and the benefits of a multi-disciplinary team and shared-decision making approach to improve patient outcomes.
Heart failure (HF) is a growing problem that affects an estimated 6.2 million adults in the United States. The availability of effective medical therapies for HF, including newer agents, offers the prospect of improved outcomes. However, HF remains underdiagnosed, and the assessment and management of HF patients may not align with evidence-based guidelines. Primary care providers (PCPs) are frequently the first line of care for patients with HF and are frequently responsible for making timely and accurate diagnoses, initiating therapy, and managing comorbidities.
**This activity is certified for CME/CE credit.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:
https://www.naceonline.com/courses/managing-heart-failure-in-primary-care-podcast**
Association of Black Cardiologists, Inc. (ABC) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Association of Black Cardiologists, Inc. designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 21222. This activity is approved for 0.5 contact hours (which includes 0 hours of pharmacology).
This educational activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.
Dr. Leana Wen and Dr. Chris Notte discuss the current state of the COVID-19 pandemic with specific emphasis on the approval of the first vaccine, testing, and answer attendee questions.
This segment was recorded on December 12, 2020, at the NACE Conversations in Primary Care broadcast.
This podcast is not accredited for CME credit.
Faculty
Leana S. Wen, MD, MSc
Visiting Professor, Health Policy and Management
Distinguished Fellow, Fitzhugh Mullan Institute for Health Workforce Equity
George Washington University School of Public Health
Washington, DC
Christopher Notte, MD
Chief Medical Officer
Abington-Lansdale Hospital
Asst. Chief Medical Information Officer
Jefferson Health
Clinical Asst. Professor, Dept. of Family &
Community Medicine
Thomas Jefferson University
Abington, PA
In this episode, NACE Host Gregg Sherman, MD, and Lizamarie Bachier-Rodriguez, MD, discuss how we can better recognize patients with multiple myeloma and manage them more appropriately, especially those with early evidence of disease.
This educational activity is supported by an educational grant from GlaxoSmithKline.
This activity is not certified for CME/CE credit.
Leana S. Wen, MD, MSc, and Neil Skolnik, MD discuss the current state of the COVID-19 pandemic with specific emphasis on the state of the pandemic, changes in CDC quarantine guidelines, an update on vaccines, and challenges surrounding long haul COVID-19 syndrome that many patients and providers are wrestling with. This was recorded on December 5, 2020, at the NACE Emerging Challenges and Clinical Updates in Primary Care broadcast.
Faculty
Neil Skolnik, MD
Professor of Family and Community Medicine
Sidney Kimmel Medical College
Thomas Jefferson University
Philadelphia, PA
Leana S. Wen, MD, MSc
Visiting Professor, Health Policy and Management
Distinguished Fellow, Fitzhugh Mullan Institute for Health Workforce Equity
George Washington University School of Public Health
Washington, DC
This podcast is not accredited for CME credit.
Dr. Malebranche talks about HIV screening, the stigma associated with testing for HIV, the high cost of testing, and provides some alternatives for your patients. He also provides guidelines for using PrEp in certain patients and discusses the importance of patient and partner preferences.
For an in-depth course on HIV, visit NACE's website at https://www.naceonline.com/courses/hiv-aids-update-2019.
For additional CME programs about a variety of topics, visit the NACE website at https://www.naceonline.com/
David J. Malebranche, MD, MPHAssociate Professor of Medicine
Department of Medicine
Morehouse School of Medicine
Atlanta, Georgia
This activity is not certified for CME/CE credit.
Dr Amman answers common questions you've posed in ADHD. Screening for ADHD and use of rating scales, screening for drug use, diet modification, managing comorbidities, monitoring treatment, drug-free holidays, the use of PRN and adjunct short-acting stimulants, and using stimulants in the older patients are discussed.
For CME programs on ADHD, visit NACE's website at https://www.naceonline.com/catalog?query=adhd
Birgit H. Amann, MD
Child and Adolescent Psychiatrist
Troy, MI
Dr Hanania answers your common questions about asthma. Screening for asthma using the the Asthma Control Test (ACT) and the importance of lung function testing, use of theophylline in current practice, how to taper inhaled corticosteroids, and treating patients with allergic diseases in asthma and the utility of desensitization and use of biologics are discussed.
Nicola A Hanania, MD, MS, FCCP
Professor of Medicine
Division of Pulmonary and Critical Care
Baylor College of Medicine
Houston, TX,
Leana S. Wen, MD, MSc, and Neil Skolnik, MD discuss the current state of the COVID-19 pandemic with specific emphasis on managing asymptomatic patients who have been exposed to the COVID-19 virus and changes to recommendations on quarantining following travel. This was recorded on August 29, 2020 at the NACE Emerging Challenges and Clinical Updates in Primary Care broadcast.
Faculty
Neil Skolnik, MD
Professor of Family and Community Medicine
Sidney Kimmel Medical College
Thomas Jefferson University
Philadelphia, PA
Leana S. Wen, MD, MSc
Visiting Professor, Health Policy and Management
Distinguished Fellow, Fitzhugh Mullan Institute for Health Workforce Equity
George Washington University School of Public Health
Washington, DC
This podcast is not accredited for CME credit.
Dr Stolar discusses the importance of the patient and provider partnership in detecting hypoglycemic episodes, implications for cardiovascular health of hypoglycemic episodes, how to probe for causes of hypoglycemia in specific patients, and when continuous glucose monitoring is useful. Different insulin options are also discussed.
For CME programs on diabetes, visit NACE's website at https://www.naceonline.com/catalog?query=diabetes
Mark W. Stolar, MD
Associate Professor of Clinical Medicine
Feinberg School of Medicine
Northwestern University
Chicago, IL
The August 8, 2020 NACE COVID-19 Update was recorded live during the Emerging Challenges and Clinical Updates for Primary Care virtual symposium. This segment features moderator Neil Skolnik. MD, and Public Health Experts Leana Wen, MD, and Seema Yasmin, MD.
In this update, Dr. Skolnik presents an update of the pandemic, and Dr Wen and Dr Yasmin present evidence-based information about the epidimiology and considerations surrounding the need for appropriate reopening of schools for the summer fall period in the United States.
Faculty
Neil Skolnik, MD
Professor of Family and Community Medicine Sidney Kimmel Medical College
Thomas Jefferson University
Philadelphia, PA
Leana S. Wen, MD, MSc
Visiting Professor, Health Policy and Management
Distinguished Fellow, Fitzhugh Mullan Institute for Health Workforce Equity
George Washington University School of Public Health
Washington, DC
Seema Yasmin, MD
Director, Stanford Health Communication Initiative
Clinical Assistant Professor, Stanford University
School of Medicine
Stanford, CA
This activity is not certified for CME/CE credit.
Migraine is commonly seen in the primary care setting, however, diagnosis and effective management of migraine can be difficult. Dr. Unger provides rapid screening questions and easy diagnostic strategies that can be incorporated in the primary care setting. He also discusses abortive and preventive management of migraine and when prophylactic interventions should be considered. Recent years have seen the emergence of a number of Calcitonin Gene-Related Peptide (CGRP) inhibitors and these are discussed in more detail.
For more education from NACE, please visit NACE's website at: https://www.naceonline.com/
Jeff Unger, MD, ABFM, FACEDirector, Unger Primary Care Medical Group
Rancho Cucamonga, CA
This activity is not certified for CME/CE credit.
Dr. Wymer answers questions about symptomatology, differential diagnosis, etiology, workup, management, and the long term trajectory of pseudobulbar affect.
For additional CME programs about various topics, visit the NACE website at https://www.naceonline.com/
Dr. James Wymer, MD, PHD, CPI, FAAN
Professor of Neurology
Director of Neuromuscular Division
The University of Florida
Gainesville, FL
This activity is not certified for CME/CE credit.
In this episode, Dr. Franck Rahaghi, Chairman of the Department of Pulmonary Medicine and Director of Alpha-1 Foundation Clinical Resource Center at the Cleveland Clinic Florida provides insights into how clinicians can do a better job screening for these patients and managing their care.
For more information about AATD and to participate in CME activities on this topic and many others, please visit http://naceonline.com
FacultyFranck Rahaghi, MD, MHS, FCCP
Chairman, Department of Pulmonary Medicine
Head, Pulmonary Education and Rehabilitation Department of Pulmonary and Critical Care
Director of Alpah1-Foundation Clinical Resource Center,
Cleveland Clinic Florida
Weston, FL
This educational activity is supported by an educational grant from Grifols and an educational grant from Takeda Pharmaceuticals U.S.A., Inc.
This activity is not certified for CME/CE credit.
Insomnia is a highly prevalent condition that presents in primary care, but nearly three quarters of all patients do not tell their providers about their symptoms. Unfortunately, insomnia can have serious consequences for patients’ daily activities, quality of life, and mental and physical health.
Recent developments in the understanding of insomnia have led to the availability of new treatment options, but clinicians may not be aware of these developments. In this episode, Dr. Paul P. Doghramji will discuss the importance of recognizing the condition, examine evidence-based treatment of insomnia, and review the role of orexin in the balance of sleep and wakefulness.
Faculty
Paul P. Doghramji, MD, FAAFP
Family Physician
Collegeville Family Practice
Medical Director of Health Services
Collegeville, PA
Host
Gregg Sherman, MD
Chief Medical Officer/Course Director
National Association for Continuing Education
Plantation, FL
This educational activity is supported by an independent medical educational grant from Eisai.
This activity is not certified for CME/CE credit.
Special guest Dr. Seema Yasmin (@DoctorYasmin) focuses on racial disparities in healthcare, their origins, and the severe impact on COVID-19 patients of color.
This NACE COVID-19 Update was recorded live during the Emerging Challenges in Primary Care May 30, 2020 virtual symposium.
Seema Yasmin, MB BChir
Director, Stanford Health Communication Initiative
Clinical Assistant Professor, Stanford University
School of Medicine
Stanford, CA
Faculty
Neil Skolnik, MD
Professor of Family and Community Medicine Sidney Kimmel Medical College
Thomas Jefferson University
Philadelphia, PA
Seema Yasmin, MB BChir
Director, Stanford Health Communication Initiative
Clinical Assistant Professor, Stanford University
School of Medicine
Stanford, CA
This activity is not certified for CME/CE credit
References
APM Research Lab Staff. THE COLOR OF CORONAVIRUS:COVID-19 Deaths by race and ethnicity in the U.S., May 27, 2020 APM Research Lab.
Braun L. Breathing race into the machine: the surprising career of the spirometer from plantation to genetics. Minneapolis: University of Minnesota Press, 2014.
Chowkwanyun, Merlin,Reed, Adolph L. Racial Health Disparities and Covid-19 — Caution and Context. New England Journal of Medicine, May 6, 2020.
Edwards, Erika. African Americans 'disproportionately affected' by coronavirus, CDC report finds. NBC News, April 8 2020.
Geronimus AT, Hicken M, Keene D, Bound J. "Weathering" and age patterns of allostatic load scores among blacks and whites in the United States. Am J Public Health. 2006;96(5):826‐833. doi:10.2105/AJPH.2004.060749
Molina N. Fit to be citizens? Public health and race in Los Angeles, 1879-1939. Berkeley: University of California Press, 2006.
Roberts SK. Infectious fear: politics, disease, and the health effects of segregation. Chapel Hill: University of North Carolina Press, 2009.
Strings, S. It's Not Obesity, It's SlaveryThe New York Times, May 25, 2020
Wen, Leana S. Four concepts to assess your personal risk as the U.S, .
Wen, Leana S, 100,000 deaths later, there are no more excuses, The Washington Post, May 21, 2020.
Yasmin, Seema, How Medicine Perpetuates the Fallacy of Race, Medscape, March 11, 2020.
Dr. Daniel Soffer and host Dr. Gregg Sherman discuss the impact of statin intolerance, emerging non-statin therapies, and strategies to reduce cardiovascular risk in statin intolerant patients.
Click here to watch the one hour webcast on this topic and Earn CME/CE credit!
Guest
Daniel Soffer, MD, FNLA
University of Pennsylvania Health System
Internal Medicine/Clinical Lipidology
Philadelphia, PA
Host
Gregg Sherman, MD
Chief Medical Officer/Course Director
National Association for Continuing Education
Plantation, FL
This activity is not certified for CME/CE credit.
This educational activity is supported in part by an educational grant from Esperion Therapeutics, Inc.
The June 6, 2020 NACE COVID-19 Update was recorded live during the Emerging Challenges in Primary Care, June 6, 2020 virtual symposium. This segment features moderator Neil Skolnik. MD, Public Health Expert Leana Wen, MD, and Family Physician with boots on the ground, Susan K. Fidler, MD.
Dr. Wen presents an update on the current state of COVID-19 pandemic and focuses on the protest and concerns about surge, and on racial disparities in healthcare and policy solutions.
Dr Fidler will address practical considerations when reopening offices.
Faculty
Neil Skolnik, MD
Moderator
Professor of Family and Community Medicine Sidney Kimmel Medical College
Thomas Jefferson University
Philadelphia, PA
Leana S. Wen, MD, MSc
Visiting Professor, Health Policy and Management
Distinguished Fellow, Fitzhugh Mullan Institute for Health Workforce Equity
George Washington University School of Public Health
Washington, DC
Susan K. Fidler, MD
Assistant Director, Family Medicine Residency Program
Abington Jefferson Health
Clinical Assistant Professor of Family and Community Medicine
Sidney Kimmel Medical College
Thomas Jefferson University
Jenkintown, PA
This activity is not certified for CME/CE credit.
Recent years have seen increasing prevalence of cardiovascular disease in women and especially women of color. Unfortunate disparities exist in recognition, optimization of risk factors, and management approaches for women. Dr Bond discusses the atypical presentations seen among women and the need for improved screening, specific diagnostic testing, management of risk factors, and improved management strategies.
For more education in cardiovascular disease, visit NACE's website at https://www.naceonline.com/catalog?query=cardiovascular
Rachel M Bond, MD, FACCMedical Director, Women’s Heart Health
Dignity Health, East Valley
Sun State Cardiology
Assistant Professor
Creighton University School of Medicine
Chandler, AZ
We are excited to discuss ADHD with world renowned expert, clinician, and researcher, Greg Mattingly, MD. Part 1 focuses on the morbidity, mortality, societal and family impact of ADHD and strategies to successfully assess, diagnose and treat ADHD patients.
Click here to access on-demand CME/CE at naceonline.com
About our Guest, Greg Mattingly, MD
Gregory W. Mattingly, MD is an Associate Clinical Professor and Psychopharmacology Course Master in the Department of Psychiatry at the Washington University School of Medicine in St Louis, Missouri.
Dr. Mattingly has dedicated the past 27 years of his career to caring for children, adolescents and adults with ADHD and associated conditions. Most importantly, as the father of a child with developmental disabilities, Dr. Mattingly understands the ongoing need for improved coordination of research, education and clinical care for our patients and their families.
Dr Mattingly's current appointments include:
- Associate Clinical Professor, Washington University School of Medicine
- President, Midwest Research Group
- Scientific Program Committee, ADHD World Congress
- Chairman APSARD Membership Committee.
Education
Dr. Mattingly graduated Summa Cum Laude in chemical engineering before pursuing his medical degree at Washington University, where he received a Fullbright Scholarship. He then completed his psychiatry residency at Washington University.
Board Certifications
- Diplomate of the American Board of Psychiatry and Neurology.
- Board certified in psychiatry with a subspecialty in adolescent psychiatry.
A Few Career Highlights
- Principal investigator for over 300 clinical trials
- Presenter at numerous national and international medical conferences
- Certified examiner for both the NFL and MLB
- Member of the board of directors for Headway House; a “club house” program for individuals with developmental disabilities and chronic mental health conditions in St Louis, MO.
Publications
Dr. Mattingly’s work has been widely published in medical journals, including:
- The Journal of Neuropsychiatry and Clinical Neurosciences
- The Journal of Clinical Psychiatry
- The Journal of Child and Adolescent Psychiatry
- Current Psychiatry
- CNS Spectrums and Postgraduate Medicine.
Click here for pubmed search results.
Awards
Dr Mattingly has received numerous awards and distinctions including:
- The Academy of Child and Adolescent Psychiatry National Leadership Award
- the Upjohn Neuropsychiatry Research Award
- Southern Psychiatric Association Research Award
This educational activity is supported by an educational grant from Shire.
This activity is not certified for CME/CE credit.
This week special guest Dr. Seema Yasmin (@DoctorYasmin) joins Dr. Leana Wen (@DrLeanaWen) and Moderator Dr. Neil Skolnik (@NeilSkolnik) for the Update. Dr Wen provides a public health update and presents four concepts for evaluating your risk of infection as practices reopen their doors. Dr Yasmin Dr. Yasmin's focuses on racial disparities in health care and the impact on COVID-19 patients and practice. This NACE COVID-19 Update was recorded live during the Emerging Challenges in Primary Care May 30, 2020 virtual symposium.
Be sure to read Dr Wen's and Dr Yasmin recent articles listed in the References at the end of this summary.
Faculty
Neil Skolnik, MD
Professor of Family and Community Medicine Sidney Kimmel Medical College
Thomas Jefferson University
Philadelphia, PA
Leana S. Wen, MD, MSc
Visiting Professor, Health Policy and Management
Distinguished Fellow, Fitzhugh Mullan Institute for Health Workforce Equity
George Washington University School of Public Health
Washington, DC
Seema Yasmin, MD
Director, Stanford Health Communication Initiative
Clinical Assistant Professor, Stanford University
School of Medicine
Stanford, CA
This activity is not certified for CME/CE credit.
References
- APM Research Lab Staff. THE COLOR OF CORONAVIRUS:COVID-19 Deaths by race and ethnicity in the U.S., May 27, 2020 APM Research Lab.
- Braun L. Breathing race into the machine: the surprising career of the spirometer from plantation to genetics. Minneapolis: University of Minnesota Press, 2014.
- Chowkwanyun, Merlin,Reed, Adolph L. Racial Health Disparities and Covid-19 — Caution and Context. New England Journal of Medicine, May 6, 2020.
- Edwards, Erika. African Americans 'disproportionately affected' by coronavirus, CDC report finds. NBC News, April 8 2020.
- Geronimus AT, Hicken M, Keene D, Bound J. "Weathering" and age patterns of allostatic load scores among blacks and whites in the United States. Am J Public Health. 2006;96(5):826‐833. doi:10.2105/AJPH.2004.060749
- Molina N. Fit to be citizens? Public health and race in Los Angeles, 1879-1939. Berkeley: University of California Press, 2006.
- Roberts SK. Infectious fear: politics, disease, and the health effects of segregation. Chapel Hill: University of North Carolina Press, 2009.
- Strings, S. It's Not Obesity, It's SlaveryThe New York Times, May 25, 2020
- Wen, Leana S. Four concepts to assess your personal risk as the U.S, .
- Wen, Leana S, 100,000 deaths later, there are no more excuses, The Washington Post, May 21, 2020.
- Yasmin, Seema, How Medicine Perpetuates the Fallacy of Race, Medscape, March 11, 2020.
In this episode, host Dr. Gregg Sherman and NACE expert faculty member, Lucia M. Novak, MSN, ANP-BC. BC-ADM, discuss Optimizing Outcomes in Diabetes With GLP-1 Therapy. Dr. Sherman and Ms. Novak discuss the glycemic and cardiorenal effects of GLP-1 RAs, the differences between injectable and oral GLP-1 RA formulations, and strategies for integrating GLP-1 RA therapy into earlier therapeutic decision-making, based on the newest treatment.
About Lucia M. Novak, MSN, ANP-BC. BC-ADMPresident and Owner, Diabetes Consulting Services, Rockville, MD
Diabetes Expert, Diabetes & Endocrine Associates, Silver Spring, MD
Ms. Novak is a board-certified nurse practitioner in both Adult Health and Advanced Diabetes Management and has over 17 years of clinical, research and educational experience in diabetes mellitus. Ms. Novak has provided her expertise pertaining to diabetes as a Contributing Author for the Lippincott Manual of Nursing Practice for the last 4 editions and is also a Contributing Author for the 1st edition of Genomic Essentials for Graduate Level Nurses. Ms. Novak serves as an Associate Editor for Clinical Diabetes.
Ms. Novak has been repeatedly recognized for her outstanding contributions as a clinician, researcher and educator. In 2015, she was designated Master Clinician for her proven leadership and clinical prowess, an accolade that placed her among the top 2% of the health care providers of the Walter Reed National Military Medical Center and is also a recipient of The DAISY Foundation Award for Extraordinary Nurses.
Her nearly 28 years of nursing experience include active duty service as a Commissioned Officer of the United States Army Nurse Corps.
This podcast episode is supported by an independent medical education grant from Novo Nordisk. This activity is not certified for CME/CE credit.
This podcast was recorded live during the Emerging Challenges in Primary Care , May 9, 2020, virtual CME/CE symposium. Part one features moderator Neil Skolnik, MD, and faculty member Leana Wen, MD. Dr Wen presents an update on the current state of COVID-19 pandemic public health challenges, impact, and strategies, as many U.S. States open earlier then federal guidelines recommend.
Faculty
Leana S. Wen, MD, MSc
Visiting Professor, Health Policy and Management
Distinguished Fellow, Fitzhugh Mullan Institute for Health Workforce Equity
George Washington University School of Public Health
Washington, DC
Moderator
Neil Skolnik, MD
Professor of Family and Community Medicine Sidney Kimmel Medical College
Thomas Jefferson University
Associate Director
Family Medicine Residency Program
Abington Jefferson Health
Philadelphia, PA
This activity is not certified for CME/CE credit.
COVID-19 Update Moderator Dr. Neil Skolnik and Faculty Member, Dr Amy Clouse, discuss COVID-19 current treatments, clinical trials, and supportive care. The experts send time on the challenges clinicians face treating and caring for patients in the absence of scientific data and evidence.
This activity is not certified for CME/CE credit.
This podcast was recorded live during the Emerging Challenges in Primary Care , May 9, 2020, virtual symposium. Part two features moderator Neil Skolnik, MD, and faculty member Christine Moutier, MD.
Dr Moutier presents on the mental health and wellbeing challenges being experienced by clinicians during this pandemic, and provides expert guidance and strategies to assist clinicians with their own and their colleagues mental health care.
The slides that were presented during this presentation are available at https://bit.ly/covid19slides-moutier
Faculty
Christine Moutier, MD
Chief Medical Officer
American Foundation for Suicide Prevention New York, NY
Moderator
Neil Skolnik, MD
Professor of Family and Community Medicine Sidney Kimmel Medical College
Thomas Jefferson University
Associate Director
Family Medicine Residency Program
Abington Jefferson Health
Philadelphia, PA
This activity is not certified for CME/CE credit.
Aaron M. Sutton, LCSW, BCD, CAADC, a Behavioral Health Consultant at Abington Family Medicine and Thomas Jefferson University, discusses approaches to clinician wellness and provides tips and strategies that can be easily done at home and at work.
This is part 3 of 3 of this COVID-19 Update.
This podcast was recorded during a panel discussion that was presented live at the NACE Conversations in Primary Care Virtual CME/CE Symposium on April 4, 2020.
The distinguished expert panel features:
- Leana Wen, MD, MSc, is an emergency room physician, public health professor at George Washington University, and previous Health Commissioner of Baltimore, MD.
- Susan K. Fidler, MD: Abington Family Medicine and Thomas Jefferson University
- Aaron M. Sutton, LCSW, BCD, CAADC, Behavioral Health Consultant, Abington Family Medicine and Thomas Jefferson University
- Neil Skolnik, MD, the moderator: Professor of Family Practice, Thomas Jefferson University.
This activity is not certified for CME/CE credit.
Susan K. Fidler, MD, from Abington Family Medicine and Thomas Jefferson University discusses strategies and tactics that are proving effective in outpatient settings to treat patients, and protect staff and patients to lower the risk of COVID-19 infection.
This is part 2 of 3 of this COVID-19 Update.
This podcast was recorded during a panel discussion that was presented live at the NACE Conversations in Primary Care Virtual CME/CE Symposium on April 4, 2020.
The distinguished expert panel features:
- Leana Wen, MD, MSc is an emergency room physician, public health professor at George Washington University, and previous Health Commissioner of Baltimore, MD.
- Susan K. Fidler, MD: Abington Family Medicine and Thomas Jefferson University
- Aaron M. Sutton, LCSW, Behavioral Health Consultant, Abington Family Medicine and Thomas Jefferson University
- Neil Skolnik, MD, the moderator: Professor of Family Practice, Thomas Jefferson University.
This activity is not certified for CME/CE credit.
Leana Wen, MD, MSc, a frequent contributor to COVID-19 coverage on CNN, MSNBC, and other outlets, is featured in this episode. This podcast was recorded during a panel discussion that was presented live at the NACE Conversations in Primary Care Virtual CME/CE Symposium on April 4, 2020.
This is part one of three of this COVID-19 Update.
Leana Wen, MD, MSc, is an emergency room physician, public health professor at George Washington University, and previous Health Commissioner of Baltimore, MD.
In addition to Dr Wen, the distinguished expert panel features:
- Susan K. Fidler, MD: Abington Family Medicine and Thomas Jefferson University
- Aaron M. Sutton, LCSW, Behavioral Health Consultant, Abington Family Medicine and Thomas Jefferson University
- Neil Skolnik, MD, the moderator: Professor of Family Practice, Thomas Jefferson University.
This activity is not certified for CME/CE credit.
This Episode was taped on March 14, 2020 when the panel discussion was presented live at the NACE Conversations in Primary Care Virtual CME/CE Symposium. The panel covers clinical presentation, the need for comprehensive public health measures to try to slow the spread of COVID-19, and practice considerations and strategies that clinicians can implement to reduce the risk of infection amongst their patients and practice teams.
The distinguished expert panel features:
- Dr. Leana Wen, a frequent contributor to COVID-19 coverage on CNN, an emergency physician and public health professor at George Washington University and previous Health Commissioner of Baltimore, MD.
- Dr. Seema Yasmin, a Clinical Assistant Professor of Medicine in Primary Care and Population Health at Stanford University and contributor to CNN COVID-19 coverage and Analysis.
- Dr. Susan K. Fidler, MD who is in Family Medicine at Abington Family Medicine and Thomas Jefferson University
- Dr. Neil Skolnik, the moderator, from Thomas Jefferson University.
This activity is not certified for CME/CE credit.
In this episode, NACE Chief Medical Officer Gregg Sherman discusses optimizing heart failure medical therapy and patient communication to improve outcomes with Eldrin Lewis MD, MPH, Associate Professor, Harvard Medical School.
Heart failure (HF) is a growing problem in the United States, affecting an estimated 5.1 million Americans ≥20 years of age. With increased life expectancy, the prevalence of HF is expected to increase 25% by the year 2030, leading to an annual healthcare cost of $70 billion. The disease is associated with several cardiovascular and non-cardiovascular risk factors, including hypertension, coronary artery disease, obesity, diabetes mellitus, HIV infection, and depression. HF is a cause for even greater concern among certain ethnic groups such as African Americans and Hispanics, in whom it occurs at an earlier age, and is associated with a lower left ventricular ejection fraction (LVEF), and a greater prevalence of risk factors such as diabetes mellitus and hypertension.
This activity is not certified for CME/CE credit.
In this episode, host Dr. Gregg Sherman and NACE expert faculty member, Dr. Mark Stolar, discuss applying recent clinical study results and new CVD risk reduction data to daily clinical practice, including patient management strategies, treatment selection considerations, and current and emerging treatments.
About Mark Stolar, MD
Mark Stolar, MD, is Associate Professor of Clinical Medicine, General Internal Medicine, and Geriatrics at Northwestern University Feinberg School of Medicine in Chicago, Illinois. Dr. Stolar received his medical degree from the University of Illinois, Chicago. He completed his fellowship in Endocrinology at the Northwestern University Medical School and his residency in internal medicine at Lutheran General Hospital. Dr. Stolar is board certified in endocrinology, diabetes, and metabolism, and internal medicine.
Dr. Stolar’s academic interests include diabetes, lipid disorders, and thyroid disease. A highly regarded speaker, he is actively involved in physician education in the area of diabetes and CV disease and has both written and presented in the US and internationally in those areas. He is currently president of the Endocrine Fellows Foundation and is actively involved in enhancing career opportunities for trainees in Endocrinology.
About NACEhttp://naceonline.com
Mission
The mission of NACE is to offer continuing education opportunities to provide learners in the fields of medicine, behavioral health, education, and related disciplines, with the most up-to-date, science-based information that will enable them to increase their knowledge, skills, confidence, and professional performance to ultimately benefit the public’s health.
Vision
The vision for NACE is to be recognized as the leader in primary care continuing education and to be known for a comprehensive suite of programs, which are tailored to the individual needs of practitioners and which emphasize innovation, outcomes, and clinical relevance.
Commitment to Compliance
NACE received re-accreditation as an ACCME provider with Commendation in March 2014 and is committed to comply with the Criteria and Standards set forth by the ACCME, the ACCME’s Content Validation Value Statement, and the AMA’s Standards and Ethical Opinions to ensure that certified educational activities meet the highest standards.
This educational activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.
This activity is not certified for CME/CE credit.
In this episode, Charles Vega, MD, Professor of Family Medicine at UC Irvine, will address the clinical impact of herpes zoster, the efficacy, tolerability, and safety of available vaccines for prevention, and strategies to promote adherence to national vaccine guidelines.
Herpes zoster, or shingles, results from reactivation of the varicella-zoster virus (VZV) that lies dormant on the dorsal horn nerve cells of the spinal cord. The annual incidence increases with age, from five cases per 1,000 population in adults aged 50-59 years to 11 cases per 1,000 population in persons aged ≥80 years. Approximately 99.5% of people aged ≥40 years born in the United States have been infected with wild-type VZV and are therefore at risk for herpes zoster. Vaccination can reduce the risk of herpes zoster and postherpetic neuralgia (PHN), and a newer vaccine with greater effectiveness is now available. However, various barriers to vaccination exist, and vaccination coverage is suboptimal.
This educational activity is supported by an educational grant from GlaxoSmithKline.
This activity is not certified for CME/CE credit.
We are excited to continue to discuss ADHD with world renowned expert, clinician, and researcher, Greg Mattingly, MD. Part 2 focuses on effective clinical strategies for the primary care provider to successfully assess, diagnose and treat ADHD patients.
Click here to access on-demand CME/CE at naceonline.com
About our Guest, Greg Mattingly, MD
Gregory W. Mattingly, MD is an Associate Clinical Professor and Psychopharmacology Course Master in the Department of Psychiatry at the Washington University School of Medicine in St Louis, Missouri.
Dr. Mattingly has dedicated the past 27 years of his career to caring for children, adolescents and adults with ADHD and associated conditions. Most importantly, as the father of a child with developmental disabilities, Dr. Mattingly understands the ongoing need for improved coordination of research, education and clinical care for our patients and their families.
Dr Mattingly's current appointments include:
- Associate Clinical Professor, Washington University School of Medicine
- President, Midwest Research Group
- Scientific Program Committee, ADHD World Congress
- Chairman APSARD Membership Committee.
Education
Dr. Mattingly graduated Summa Cum Laude in chemical engineering before pursuing his medical degree at Washington University, where he received a Fullbright Scholarship. He then completed his psychiatry residency at Washington University.
Board Certifications
- Diplomate of the American Board of Psychiatry and Neurology.
- Board certified in psychiatry with a subspecialty in adolescent psychiatry.
A Few Career Highlights
- Principal investigator for over 300 clinical trials
- Presenter at numerous national and international medical conferences
- Certified examiner for both the NFL and MLB
- Member of the board of directors for Headway House; a “club house” program for individuals with developmental disabilities and chronic mental health conditions in St Louis, MO.
Publications
Dr. Mattingly’s work has been widely published in medical journals, including:
- The Journal of Neuropsychiatry and Clinical Neurosciences
- The Journal of Clinical Psychiatry
- The Journal of Child and Adolescent Psychiatry
- Current Psychiatry
- CNS Spectrums and Postgraduate Medicine.
Click here for pubmed search results.
Awards
Dr Mattingly has received numerous awards and distinctions including:
- The Academy of Child and Adolescent Psychiatry National Leadership Award
- the Upjohn Neuropsychiatry Research Award
- Southern Psychiatric Association Research Award
This educational activity is supported by an educational grant from Shire.
This activity is not certified for CME/CE credit.
Joining Dr. Gregg Sherman for this episode is Dr. James Underberg for a discussion about the impact of Hyperlipidemia management on Cardiovascular Risk Reduction.
Click here to access NACE on-demand CME/CE courses on cardiovascular disease
Dr. Underberg is a Clinical Assistant Professor of Medicine at NYU Medical School & NYU Center for CV Prevention, Director of the Bellevue Hospital Lipid Clinic and Past President of the National Lipid Association. We very excited to spend a few minutes with Dr. Underberg to discuss current clinical guidelines, his insights about the evolving state of lipid management, and the impact of Hyperlipidemia management on Cardiovascular Risk Reduction.
This activity is supported by educational funding provided by Amgen.
This activity is not certified for CME/CE credit.